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ABSTRACT OF DISSERTATION

CARDIO-RESPIRATORY INTERACTION AND
ITS CONTRIBUTION IN SYNCOPE
A hypothetical causal link between ventilatory regulation of carbon dioxide and
development of syncope during orthostatic challenges is reduction in arterial partial
pressure of carbon dioxide and resultant reduction in cerebral blood flow. We performed
two experiments to investigate the ventilatory sensitivity to carbon dioxide and factors
affecting cerebral autoregulation (CA). We also studied the nonlinear phase coupling
between cardio-respiratory parameters before syncope.
For experiment one, in 30 healthy adults, we stimulated chemo and baro reflexes
by breathing either room-air or room-air with 5 percent carbon dioxide in a pseudo
random binary sequence during supine and 70 degree head up tilt (HUT). Six subjects
developed presyncope during tilt.
To determine whether changes in ventilatory control contribute to the observed
decrease in PaCO2 during HUT, we assessed ventilatory dynamic sensitivity to changes
in PaCO2 during supine and 70 degrees HUT. The sensitivity of the ventilatory control
system to perturbations in end tidal carbon dioxide increased during tilt.

To investigate nonlinear phase coupling between cardio-respiratory parameters
before syncope, bispectra were estimated and compared between presyncopal and
non-presyncopal subjects. Our results indicate that preceding presyncope, nonlinear
phase coupling is altered by perturbations to baro and chemo reflexes.
To investigate the effects of gender in CA, we selected 10 men and 10
age-matched women and used spectral analysis to compare differences in CA between
men and women. Our results showed that gender-related differences in CA did exist and
gender may need to be considered as a factor in investigating CA.
To investigate the influence of induced hypocapnia on CA in absence of
ventilatory variability, we performed experiment two in which subjects were randomly
assigned to a Control (under normocapnia) or Treatment (under hypocapnia) group. Both
groups voluntarily controlled their breathing pattern yet two groups breathed in air with
different levels of carbon dioxide. Our results show that changes in mean blood pressure
at middle cerebral artery level were less transferred into mean cerebral blood flow in the
Treatment group than in the Control group, suggesting better CA under hypocapnia
relative to under normocapnia.
KEYWORDS: Autonomic Control; Bispectrum; Cerebral autoregulation; Gender
differences; Hypocapnia.
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Chapter 1 Introduction

Hemodynamic and respiratory parameters adjust in response to changes in posture from
supine to an upright position. During orthostasis, fluid shifts toward the lower extremities
because of gravitational effects. A slight increase in mean blood pressure, heart rate and
peripheral resistance occurs to compensate for this shift (13). Decreases in end tidal
(about 4mmHg) and arterial partial pressures of carbon dioxide (about 2 mmHg) are also
observed during head up tilt (60, 71). Although decreases in end tidal carbon dioxide
(ETCO2) and arterial partial pressure of carbon dioxide (PaCO2) are consistently
observed during head up tilt, the mechanisms responsible for such decreases remain
unclear (60).
Recent studies (36, 39, 52) have shown that alterations in the interaction between
hemodynamic and respiratory regulation may contribute to posturally mediated
orthostatic intolerance and unexplained syncope (7, 52). Hyperventilation, hypocapnia
and increase in respiratory variability were observed in some syncopal subjects prior to
syncope (39, 52). A hypothetical causal link between ventilatory regulation of CO2 and
development of syncope is reduction in PaCO2 and the resultant reduction in cerebral
blood flow. The above results suggest that it is important to investigate mechanisms via
which CO2 is decreased during tilt because it is possible that alterations in these same
mechanisms may also be responsible for, or contribute to, initiation of events that
ultimately culminate in unexplained syncope.
Our first objective in the present study was to determine if sensitivity of ventilatory
regulation in response to perturbations in PaCO2 is diminished during tilt. We
hypothesized that diminished ventilatory sensitivity to PaCO2 may accommodate
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decreased levels of PaCO2 resulting from a change in perfusion and other effects of
change in posture. We assessed dynamic sensitivity of ventilatory regulation in response
to changes in PaCO2 during supine and 70 degree passive head up tilt. Our results showed
that during tilt, instead of a decrease, ventilatory sensitivity to CO2 was enhanced
compared with that in supine. The observation that during tilt ETCO2 decreased while
minute ventilation increased, combined with increased sensitivity, suggests that with
postural change there may be a change in the ‘set point’, i.e. change in the level of PaCO2
that is regulated.
The widely used spectral and multi-variate analyses, such as transfer functions and
coherencies (33, 72), are based on the assumption that the underlying system is linear.
However, as is the case with many physiological systems, complex cardio-respiratory
control systems may have nonlinear components as well. Previous studies provide
evidence of nonlinear components in heart rate variability (8, 22, 29). Non-linear indexes
reveal information regarding cardiovascular regulation and cardio-respiratory interactions
that is different from information obtained using linear variability measures (10, 44, 64,
65, 70). Hoyer et. al. (25) suggested that one possible source of nonlinearity in these
systems is coupled neuronal generators within the medulla that are related to
cardiovascular and respiratory controls (74).
Our second objective was to explore the nonlinear dynamic changes in presyncopal
subjects compared with non-presyncopal subjects using bispectral analysis. We used the
bispectrum to estimate non-linear phase coupling. Bispectral analysis can be used to
detect non-linear properties and quadratic phase coupling (QPC) (63). This method has
been used to investigate a variety of physiological systems, such as analysis of EEG (23,
50, 51, 63), sympathetic nerve discharge (21) and ECG (40, 56). In the present study,
auto and cross bispectrum were used to compute phase coupling among oscillations at
different frequencies in and between RR intervals, systolic blood pressure (SBP), tidal
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volume (Vt), ETCO2 and mean cerebral blood flow velocity (CBFM) from groups of
subjects who did and did not develop orthostatically mediated presyncopal symptoms.
Cerebral blood flow (CBF) is maintained at a relatively constant level despite changes in
arterial blood pressure. This phenomenon, known as cerebral autoregulation (CA), occurs
between blood pressure limits of approximately 50 and 170 mm Hg (2). The
pressure-dependent activation of the smooth muscle in the arterioles of the cerebral
vascular beds is the main regulator. A lack of blood flow for a few seconds leads to
syncope and for a few minutes leads to permanent brain damage, therefore, it is very
important to maintain the cerebral blood flow. Impaired CA is thought to contribute to
the onset of syncope (33).
In one study, the incidence of presyncope in astronauts after spaceflight was higher in
women (35%) than in men (5%) (20). Also orthostatic intolerance happened 3-4 times
more frequently in young women than men (59). Gender-related differences in cerebral
blood flow velocity (CBFV) (3, 45), cerebral vasomotor reactivity (30) and
cerebrovascular CO2 reactivity (31, 32) have been investigated in several recent studies.
The results showed that women have higher CBFV (3, 45), higher CO2 reactivity (31, 32)
and higher vasomotor reactivity (30) than men. However, gender-related differences in
CA are somewhat less explored. Our third objective was to compare the CA between
women and men using spectral analysis methods (67).
The partial pressure of carbon dioxide in arterial blood also plays an important role in
cerebral blood flow regulation. CO2 is known as a vasodilator, therefore, increases in
level of CO2 lead to a decrease in the cerebral vascular resistance (CVR) and an increase
in the CBF, and vice versa. A study by Aaslid R et. al.(2) used acute step decreases in
blood pressure to investigate the response rate of CA (the response rate of full restoration
of blood flow to the pretest level) under different CO2 levels. The rate of regulation in
hypocapnia, normocapnia, and hypercapnia was 0.38, 0.20, and 0.11/sec. In recent
3

studies (33, 34, 61, 72, 73) spectral analysis methods, such as transfer function and
coherence, were used to investigate the dynamic relationship between blood pressure and
cerebral blood flow. Zhang et. al.(72) found that CA can be modeled by a transfer
function with the quality of a high-pass filter in the frequency range of 0.07-0.30 Hz. The
gain relating mean blood pressure at middle cerebral artery level (BPMCA) to CBFM
increased during 5% CO2 inhalation (72). In another study by Edwards et. al.(16), a
two-input (BPMCA and ETCO2) and one-output (CBFM or CVR) autoregressive moving
average (ARMA) model was used to investigate the relationship between CBF and two
factors which will affect CBF simultaneously. The method was able to attribute the
variations in CBFM to changes in BPMCA and ETCO2 separately and simultaneously.
Changes in respiration affect intra-thoracic pressure, cardiac output and heart rate
(through the mechanism named respiratory arrhythmia sinus (RSA)). Control of
breathing pattern will also affect CA (15, 17). In most of previous studies, respiratory
pattern control was conducted by following auditory signal (16, 17). This auditory
feedback method can only control the respiratory rate. In our current study, we used a
visual feedback method, by which we can control both breathing rate and tidal volume,
thus minute ventilation calculated as the ratio of tidal volume to breath duration was also
controlled. The breathing pattern was controlled so that the CO2 effects on cerebral
regulation could be investigated without concomitant effects from changes in respiration.
Our fourth objective was to investigate hypocapnia’s effects on CA with minor changes
in breathing pattern using spectral analysis methods. To accomplish our fourth objective,
we asked our subjects to breathe room air with 2.5% CO2 during supine and then
maintained their ventilation constant via voluntary control of respiratory rate and tidal
volume. During HUT, we removed inspired CO2 in one group of subjects (Treatment
group) while the subjects’ ventilation was maintained at previously adapted levels. For
these subjects in the Treatment group, they were under hypocapnia with minor changes in
their ventilation.
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The outline of the dissertation is as follows. Chapter 1 describes the background of our
study and gives the four specific objectives of our study. Chapter 2 gives a brief review
of the involved physiology background. Chapter 3 presents the experimental protocols
and setup for experiment one and two. Chapter 4 describes the data analysis methods
used in this dissertation. Chapter 5 includes results from both experiments. Chapter 6
discussed the results. The first three objectives were accomplished by experiment one and
the fourth objective by experiment two.
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Chapter 2 Background

2.1

Syncope

In this section, the definition, symptoms and possible causes of syncope are briefly
reviewed.
2.1.1

Definition of syncope

Syncope is defined as temporary loss of consciousness. It is better known as "fainting" or
"passing out." It is often a sudden loss of postural tone followed by rapid spontaneous
recovery. Recovery usually takes seconds to minutes. Syncope occurs in all age groups
from pediatric to elderly, accounting for 3 percent of emergency room visits and 6
percent of hospital admissions every year (62). Many people have one episode of syncope
in their lifetime and if symptoms of syncope do not repeat no treatment is necessary.
Recurrent episodes, however, require diagnosis and treatment. Syncope itself will not hurt
the person when he falls down and recovers the cerebral blood flow quickly. However,
the sudden fall poses an injury threat.
2.1.2

Symptoms of syncope

Pre-syncopal symptoms: Pre-syncopal symptoms happen before the person completely
loses consciousness. The person feels dizzy, lightheaded, warm, sweaty, nausea and has
blurred vision or tunneled vision (can only look at the area in the front), palpitation etc.
These can be used as warnings of syncope. Once the person has the above symptoms he
should sit down or lie down to prevent him from developing syncope.
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Syncope symptoms: During syncope there is a complete loss of consciousness. Some
people will faint without any warning, i.e. without any presyncopal symptoms (19).
2.1.3

Causes of syncope

The direct reason of syncope is temporary insufficient blood flow to the brain. Though
constituting only 2% of total body weight, the brain receives 15% of the cardiac output.
Oxygen and glucose demand for brain is high when compared with other organs (except
heart). A lack of blood flow for a few seconds will lead to syncope and for 3 – 4 min will
lead to permanent brain damage.
Syncope can be put into two major classifications: cardiac syncope and non-cardiac
syncope. In the case of cardiac syncope, the person has an irregular cardiac rhythm
(arrhythmia) or abnormalities in the structure of the heart. The heart does not function
properly so blood flow supply in the brain is inadequate. This is the most dangerous type
of syncope. In the case of non-cardiac syncope, the person’s heart function is normal.
Non-cardiac syncope includes neurologic, psychiatric, orthostatic hypotension and
neurally mediated syncope. Severe loss of blood flow, associated with blood loss, chronic
diarrhea, and dehydration, will also lead to syncope.
2.1.4

Neurally mediated syncope

Neurally mediated syncope (NMS) is also called neurocardiogenic or vasovagal syncope
and it is the most frequent cause of fainting. It is one type of non-cardiac syncope. In this
type of syncope, the heart is working properly while the autonomic nervous system which
controls the heart is not. NMS often occurs when blood pressure drops (hypotension) and
the blood flow supplied to the brain is not enough (62).
Two most common phenomena observed before NMS is hypotension (low blood pressure)
and bradycardia (slow heart rate). Prior to the onset of syncope, either blood pressure
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and/or heart rate has a sudden drop suggesting that vagal tone is enhanced and
sympathetic tone is diminished before syncope.
When the person moves from supine to standing position, the blood volume shifts to the
lower extremities (like legs) because of the gravitational effects. The reflex mechanism
like the baroreflex will adjust the cardiovascular system to try to restore the blood flow to
the original level. The baroreceptors will detect the changes in blood pressure then
through enhancing the sympathetic tone (increase heart rate and vascular resistance) and
diminishing the parasympathetic tone the blood pressure and cerebral perfusion is
restored. However, in the person who has syncope problems, the adaption is not adequate
and cannot compensate the changes in blood pressure and cerebral perfusion caused by
orthostatic responses.
There are several possible explanations for NMS (49), including:
-Ventricular theory. The blood pressure drop is detected by baroreceptors and the
sympathetic activity is enhanced so the heart is beating faster and stronger, while the
ventricle is already part empty (inadequate preload). Similar to Bezold-Jarisch Reflex, the
onset of syncope involves an increase in vagal efferent discharge to the heart which
causes bradycardia and hypotension (49, 62).
-Baroreflex dysfunction theory. Some researchers believe the reason for the syncope is
the baroreflex dysfunction. Either baroreceptors can not detect the changes or the reflex
cannot compensate for the hemodynamic changes (48).
-Respiration theory. Hyperventilation, hypocapnia and yawning have been reported were
observed prior to the onset of syncope (52). It is possible that hypocapnia caused by
hyperventilation might lead to reduction in CBF leading to syncope. The depth of
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respiration also increases the blood pressure oscillations in presyncopal patients (18).
Respiration might also play a role in the onset of syncope.
-Cerebral blood flow dysregulation. Cerebral autoregulation is an intrinsic property to
maintain the cerebral blood flow in face of oscillations in systemic blood pressure. In
case of impaired cerebral autoregulation, the blood flow cannot be maintained.
2.1.5

Tilt table test

Tilt table test is widely used in diagnosing syncope in both clinical setting and research
laboratories. Tilt table test is designed to evaluate the orthostatic response based on the
fact that prolonged standing could lead to venous pooling. In a tilt table test, the patient is
strapped to a table, which is then tilted to a head up tilt position. During tilt, the subject is
advised to do not move much. When the subject has any syncopal or presyncopal
symptoms the result is considered a positive test. Contracting leg muscles will compress
the venous vessels and since the venous valves are unidirectional, venous return is forced
back towards the heart. In contrast to standing, during tilt table test the movement is
passive and the skeletal muscle pump is inhibited.
2.1.6

Treatment for neurally mediated syncope

One episode of NMS usually does not need treatment. Repeated syncope may need
medication. Several types of drugs have been used including beta blockers, serotonin
uptake inhibitors, florinef and midodine. In 60-70% of the syncopal cases, these drugs
help reduce the episodes of syncope (1). People who have syncope problems should drink
plenty of water and be on a high-salt diet to prevent dehydration and syncope. When they
have pre-syncopal symptoms they should lie down immediately with both legs elevated
(62).
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2.2

Cardio-respiratory interactions

In this section, cardiovascular and respiratory regulation related to our study will be
reviewed.
2.2.1

Nervous control of cardiovascular system

Increase in sympathetic nervous system activity will lead to increase in heart rate
(positive chronotropy) while parasympathetic or vagal activity will have the opposite
effects. Increase in sympathetic activity will also lead to the enhancement of atrial and
ventricular contractility (positive inotropy). The changes of sympathetic and
parasympathetic activity are often reciprocal. An increase in heart rate involves an
increase in sympathetic and a decrease in parasympathetic regulation of the SA-node.
Sympathetic activity increase will also result in vasoconstriction and an increase in
peripheral resistance.
2.2.2

Short-term regulation of blood pressure through baroreflex

Baroreflex is involved in short term regulation of blood pressure. The baroreceptors
located in carotid sinuses and aortic arch will detect the stretch in the vessels and then
send afferent signal through carotid sinus nerve (part of the glossopharyngeal nerve) and
vagus nerves respectively to the nucleus of the tractus solitarius (NTS) in the medulla.
Increase in blood pressure will lead to an increase in the frequency of baroreceptor nerve
firing and will inhibit the vasoconstrictor regions in the medulla. This inhibition will
result in peripheral vasodilation. By an increase in parasympathetic and decrease in
sympathetic activity the heart rate is decreased. All of these changes help decrease the
blood pressure and restore the blood pressure to the normal value. Regulation by the
baroreflex is short-term and effective when the changes in blood pressure or cardiac
output are abrupt. The long term regulation of blood pressure depends on fluid balance
and the kidney. Long term regulation is not that important during investigation of
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syncope related issues as syncope is likely an acute problem. Certain hormones, such as
epinephrine and insulin, also affect heart rate and thus blood pressure.
2.2.3

Autonomic control of breathing

There are two types of chemoreceptors (for CO2 and O2): central and peripheral receptors.
Central chemoreceptors, located at ventral surface of medulla are responsive to PaCO2 by
way of hydrogen ion concentration in cerebrospinal fluid (CSF). Central chemoreceptors
increase ventilation in response to increased PaCO2 level. Peripheral chemoreceptors,
located in aortic arch and carotid bodies, are responsive to arterial partial pressure of
oxygen (PaO2) and PaCO2. Peripheral chemoreceptors increase ventilation in response to
decreases in PaO2. Mechanoreceptors (lung stretch receptors), located in the chest wall
and lungs, sense the lung volume change. The afferent signal sensed from the receptors is
sent to the respiratory center in medulla and then efferent signal is sent to control the
respiratory muscles to control breathing and adjust ventilation.
The regulation of breathing is dependent on different state of the body. For example,
during sleep and wakefulness the breathing is differently regulated. This is due to a group
of interneurons known as the reticular activation system that affect the controller by the
state of alertness.
2.2.4

Respiration alters venous return

During inspiration, the intra thoracic pressure is decreased and thus the central venous
pressure is decreased. The increase of the pressure gradient between extra thoracic and
intra thoracic veins accelerates the venous return to the right atrium. During expiration,
the flow decelerates. However, the momentum as well as the valves in the veins of the
extremities prevents the blood from flowing backward. According to the Frank-Starling
law of the heart, the heart adapts to the rate of venous return and pumps all the blood
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from venous return, therefore when venous return is affected by respiration, cardiac
output will be affected accordingly.
2.2.5

Gravity effects on cardiac output

When a person shifts from supine to the standing position, about 300-800ml (5) blood
will go to the lower extremities (legs) because of gravitational effects, which is called
venous pooling. This blood shift is caused by the compliance of the blood vessels. When
a person stands, the blood in the vessels will distend the blood vessels because of
gravitational effects. Since the compliance of venous vessels is much larger than arterial
vessels, the distention is more prominent in venous vessels than in arterial vessels. This
venous pooling will cause a decrease in cardiac output.
2.3

Cerebral hemodynamics

Syncope occurs when cerebral perfusion globally decreases. Glucose is the primary
metabolic substrate of the brain (75). Brain tissue depends on adequate blood flow to
provide enough glucose. Unlike other organs, brain tissue has no significant storage
capacity for glucose, therefore, a decreased cerebral perfusion for only 3-5 seconds
results in syncope.
Like the blood flow in other body parts, the cerebral blood flow will respond to both
myogenic and metabolic regulation. The myogenic regulation of cerebral blood flow
indicates that blood flow is maintained almost constant in face of the perfusion pressure
oscillations. In human, when the blood pressure is within 60-160 mmHg, the blood flow
will be relatively constant in a narrow range averaging 55ml/min/100g of brain (5) . This
property of the brain is commonly referred to as cerebral autoregulation. During cerebral
autoregulatuion, vascular smooth muscle contracts when pressure increases and the
vessels are stretched. The smooth muscle will relax when the pressure decreases. Mean
arterial pressure less than 60 mm Hg will result in the decrease of cerebral blood flow and
12

syncope. The metabolic regulation describes that the blood flow will be regulated by the
local chemical environment, such as CO2 tension. The cerebral vessels are very sensitive
to CO2 levels. Increase in PaCO2 will lead to cerebral vasodilation and an increase in
cerebral blood flow, and vice versa (9).
2.4

Spectral analysis of physiological signals

Power spectral analysis and analysis based on it such as transfer function and coherence
are quantitative tools widely used in investigating physiologic and patho-physiological
phenomena.
Power spectral analysis of heart rate and blood pressure is commonly used to investigate
the role of the autonomic nervous system in cardiovascular system regulation. The very
low frequency (below 0.04 Hz) reflects changes in thermal regulation. The low frequency
(around 0.1 Hz) spectral power of heart rate is considered to be affected by both
sympathetic and parasympathetic (vagal) systems, while the high frequency spectral
power of heart rate (within respiratory frequency region) is considered to be mediated
solely by the parasympathetic system via respiration (24).
Spectral analysis methods, such as transfer function and coherence between blood
pressure, cerebral vascular resistance and cerebral blood flow have been used to
investigate cerebral autoregulation (7, 33, 72). If the CBFV demonstrates large amplitude
oscillations (higher CBFV variability) or blood pressure changes are more correlated with
changes in CBFV (higher coherence and larger gain), this would indicate that CA is not
functioning properly. Therefore, higher CBFV variabilities, higher coherence and larger
gain are considered to be related to impaired CA.
Higher order spectral analysis, especially bispectral analysis, has also been widely used in
processing physiological signals. Power spectral analysis does not provide any phase
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information of the signals, whereas bispectra can determine whether two harmonically
related frequency components are quadratically phase coupled.
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Chapter 3 Methods
This chapter presents the information regarding subjects who participated in the studies,
the experimental protocols, the instrumentation used and the experiment setup.
3.1

Subjects

All subjects were non-smokers and did not have any history of cardiovascular or lung
diseases. The female subjects were not pregnant, did not use birth control pills and were
in the pre-menopausal stage.
For experiment one, thirty-one healthy adults (male: 14, female: 17, mean age 27, range
20-41) participated in our study. When we started these studies, we had planned to assay
for catecholamines and thus used IV placement in subjects who were enrolled at first.
Subsequently, we determined not to pursue this analysis and thus subjects enrolled after
an initial group of 8 subjects did not have an IV line.
For experiment two, 18 healthy adults (male: 10, female: 8, mean age 28, range 20-42)
participated in our study.
All studies were approved by the Institutional Review Board at the University of
Kentucky. All subjects gave written informed consent.
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3.2
3.2.1

Experimental protocol
Protocol for experiment one

The experimental protocol, as shown in Figure 3.1, included four parts: Supine Control,
Supine PRBS, Tilt PRBS and Tilt Control. In the first part (10 minutes), the subject was
asked to lie down on a tilt table and breathe only room air. In the second part (10
minutes), the subject breathed either room air or room air plus 5% CO2 according to a
Pseudo Random Binary Sequence (PRBS). In the third part (10 minutes), the subject was
passively tilted to a 70 degree head up tilt position, while still breathing either room air or
room air plus 5% CO2. In the fourth part (20 minutes), they breathed room air only. The
total length for tilt was 30 minutes or less if the subject developed any pre-syncopal
symptoms. If a subject developed any pre-syncopal symptoms, the tilt table was returned
to supine immediately. At the end of the 30 minutes, the subject was tilted back to supine
for a 10-min-recovery.

End tilt
Lying down

70 degrees head up tilt
Start test

30 min or less

End

10 min control

Breathing room air

Instrumentation

10 min air or air

10 min air or

plus CO2

air plus CO2

breathing

breathing

Supine

Supine

Tilt

Tilt

Control

PRBS

PRBS

Control

Supine

Figure 3.1 Schematic of the protocol for experiment one. The figure shows the four
sections of the study from where data were collected: Supine Control; Supine PRBS; Tilt
PRBS; and Tilt Control.
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3.2.2

Protocol for experiment two

The protocol for experiment two is shown in Figure 3.2. Subjects were randomly
assigned to a Control or Treatment group. Treatment group had 10 subjects and Control
group had 8 subjects. After instrumentation, subjects from both groups were placed in
supine position. Baseline data were collected for 10 minutes (stage 1). After collecting
the baseline data, instantaneous tidal volume was calculated and projected on a screen
along with a target breathing pattern. To maintain their CO2 at a level similar to the level
of CO2 observed during baseline, peak value of the target breathing pattern was increased
accordingly, while the respiratory rate was maintained constant. Subjects voluntarily
controlled their breathing and tried to make their instantaneous tidal volume curve follow
the target pattern for 5 minutes in supine position (stage 2). After stage 2 the subjects
were passively tilted to a 70 degree head up tilt position for 30 minutes. All subjects
breathed a mixture of air plus 2.5% CO2 during the first 5 minutes of tilt (stage 3). They
still controlled their breathing but the target pattern’s peak value was increased to
maintain their end-tidal CO2 value to be relatively unchanged from the baseline data.
Thereafter, subjects in the Treatment group were switched to breathe only room air, while
subjects in the Control group continued breathing the CO2 mixture. They kept controlling
their breathing pattern while the peak volume remained unchanged for the rest of the
study (stage 4). The protocol for the first three stages is same for both groups, while
during stage 4, treatment group breathe only room air while control group breathe room
air with 2.5% CO2. If a subject developed any pre-syncopal symptoms, the tilt table was
returned to supine position immediately.
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Start

End controlled breathing

Start controlled breathing

End
70 degrees head up tilt

Supine

Room air plus CO2 breathing (control group)

Room air
breathing
1
10 min

Supine rest
Room air
breathing

Room air breathing (treatment group)
2

3

5 min

5 min

4
25 min

Figure 3.2 Schematic of the protocol for experiment two. The figure shows the four
sections of the study from where data were collected. The only difference between
treatment and control group is during stage 4.

3.3

Instrumentation

Lead II ECG (Monitor 90603A, Spacelab, Redmond, WA) was recorded. Continuous
blood pressure waveform was recorded non-invasively from the middle finger in the left
hand (Finapres BP monitor, Ohmeda, Madison, WI). A sling was used to hold the left
hand at the heart level. An automated cuff blood pressure monitor was placed on the right
arm for validating the blood pressure values from the Finapres BP monitor. The middle
cerebral artery was insonated to measure CBFV by a Transcranial Doppler probe
(Multigon Model 500M) at 2 MHz in the right middle temporal window. The probe was
fixed by a headband. The subject breathed through a mouthpiece which was connected to
pneumotachograph (Fleisch). A nose clip was used to insure that the subjects breathed
only through their mouths. An infrared CO2 monitor (Novametrix) was used to measure
CO2 fraction in inspired and expired gas. Tilt angle was measured by measuring the
voltage across a potentiometer in a bridge circuit. All data were sampled at 500Hz by a
data acquisition system (Windaq® DI-720).
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3.4
3.4.1

Experimental setup
Experiment one

As shown in Figure 3.3, the subject breathed through a mouthpiece which was connected
to two balloon valves. If one balloon is inflated then the other will deflate, such that only
one balloon is inflated at one time. Balloon valve A was open to room air and valve B
was connected to an airbag with air plus 5% CO2. If balloon A is inflated (balloon B is
deflated), the subject will breathe room air plus 5% CO2; if balloon B is inflated (balloon
A is deflated), the subject will breath room air. The inflating and deflating of the balloon
were controlled by a PRBS. PRBS was generated such that the incidence of “0” and “1”
is almost equal in a given time interval. PRBS was pre-generated and stored in the
computer. The custom written program collected the airflow signal and detected the
expiration (37). During each expiration, the program will send out either “0” or “1”
through the D/A board different voltage was sent to an Automatic Controller (Hans
Rudolph) of the balloons. If “1” is send out, the balloon will be inflated, otherwise if “0”
is send out, the balloon will be deflated. One end of the valve was connected to an airbag
with 5% CO2 balanced with 21% O2 and 74% N2. The other end of the valve was open to
room air. Since the incidence of “0” and “1” is almost equal, the chance of the subjects to
breathe room air or room air plus 5% CO2 is almost the same. Therefore, on the average
the subjects breathed 2.5% CO2.
The rational for using PRBS type input is that PRBS widens input spectrum which allows
us to investigate the frequency response of the system in a wide frequency range. Since
the signal is only changed during expiration, the upper frequency limit for the input
spectrum is the inverse of averaged breath duration.
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Balloon valves

Air

A

Air plus 5 % CO2
B

Pneumotach
Subject

Figure 3.3 Setup for PRBS breathing. One of the two balloon valves is inflated and the
other is deflated. The subject will breathe in air plus 5% CO2 as shown above.
The following variables were recorded during experiment one:

Airflow, CO2 level,

ECG, Blood pressure, PRBS, Cerebral blood flow velocity, Tilt angle.
3.4.2

Experiment two

The subject’s airflow and CO2 level in their airflow were collected for the first 10
minutes (baseline data). The offline program in Matlab® calculated the average tidal
volume, breath duration and end tidal CO2 from the baseline data. Using a LabView®
program, the target pattern was generated from combining two sine waves with different
period as shown in Figure 3.4. The ascending part is the inspiration part and the descending
part is the expiration part. The time duration for inspiration and expiration ratio is 2:3. The
initial peak value for the target pattern was the average tidal volume calculated from the 10
min baseline data.
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0
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duration (T)

breath

Figure 3.4 The target pattern generated from combining two sine waves.
The following variables were recorded during experiment two:
blood pressure, cerebral blood flow velocity, tilt angle.
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airflow, CO2 level, ECG,

Chapter 4 Data Analysis
4.1

Preprocessing procedure

From the airflow signal, the zero-crossing were located and the start and end of a breath
were identified. The airflow signal within each breath was integrated to get instantaneous
tidal volume. Within each breath, tidal volume (maximum value of the lung volume
during that breath) and breath duration (the time between the start and the end of that
breath) were calculated. Breath by breath ventilation ( V&E ) was calculated as the ratio of
tidal volume to breath duration. Inspired and ETCO2 were detected from each breath.
These breath by breath values were held constant during that breath, then sub-sampled at
5 Hz or sub-sampled at average breathing frequency for that particular subject.
From the ECG signal, we used an algorithm developed by Macdonald et. al.(43) to detect
R peaks. Briefly, a band pass filter (20-60 Hz) was used to suppress baseline wandering
and high frequency noise. The absolute value of the filtered signal was then compared
with an automatically adjusting threshold. RR intervals were calculated as the time
duration between two R peaks. Maximum and minimum values of the blood pressure
during each beat were computed as systolic and diastolic blood pressure. Peak and
average value of the cerebral blood flow within each beat was the peak (CBFP) and mean
cerebral blood flow velocity. Blood pressures at the heart level adjusted by the height
from the heart level to the eye level were used as estimation for BPMCA. Cerebral vascular
resistance index (CVR) is estimated as the ratio of BPMCA to CBFM. These beat by beat
values were held constant within each beat. The resulting piece-wise continuous signals
were sub-sampled at 5 Hz.

22

The results from pre-processing sampled at 5Hz were used in spectral analysis, such as
coherence, transfer function and bispectral analysis. Those results sampled at average
breathing frequency were used in parametric system identification of ventilatory
sensitivity to CO2.
4.2

Parametric system identification

Similar to the methods used by Lai and Bruce(37), a generalized linear model as shown
in Figure 4.1 was used to represent the ventilatory control system. In order to estimate the
ventilatory response, a Box-Jenkins model was used (37, 41):

y ( n) =

B(q)
C (q)
u (n − nk ) +
e( n )
F (q)
D(q)

n = 1,2,..., N

(4.2.1)

In equation 4.2.1, u(n) is the input of the system, which, for open loop or controller
responses is ETCO2 (an approximation of PaCO2 (4, 6)), and for the closed loop
responses, the input is inspired volume of CO2 (inspired CO2 fraction multiplied by tidal
volume). In equation 4.2.1, y(n) is the output of the system V&E , e(n) is random noise, n
represents (re-sampled) breath number, nk is time delay between output and input
(representing circulation time between the lungs and the site of the chemoreceptors), and
N is the total number of breaths. The letters B, C, D, and F represent polynomials in a
shift operator q.
B (q ) = b0 + b1 q −1 + b2 q −2 + ... + bnb q − nb ; F (q) = 1 + f 1 q −1 + f 2 q −2 + ... + f nf q − nf ;

C (q) = 1 + c1 q −1 + c 2 q −2 + ... + c nc q − nc ; D(q ) = 1 + d1q −1 + d 2 q −2 + ... + d nd q − nd ; (4.2.2)
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The orders of polynomials B, C, D, and F are nb, nc, nd, nf. We used a prediction error
method (PEM) to estimate model parameters nn= [nb nc nd nf nk]. Similar to the method
used by Lai and Bruce (37), optimal parameter values were determined by starting from
initial values of nn=[1 0 0 1 1] and increasing one of these five values by 1 each time
until nn=[4 3 3 3 4]. The selection of optimal nn parameters was based on a combination
of three criteria: final prediction error (FPE), whiteness of residuals and lack of
statistically significant correlation between the input signal and residuals. Because our
protocol for experiment one for ventilatory sensitivity assessment was very similar to that
used by Lai and Bruce, we confirmed that the selected model was consistent with that
reported by them. To get better estimates of model parameters at lower frequencies (37),
we included data during last five minutes of Supine Control with those during Supine
PRBS to calculate ventilatory response during supine posture. Similarly, data during Tilt
PRBS and the first five minutes during Tilt Control were used to calculate ventilatory
response during tilt.
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Inspired

(a) CO
2

volume

(b)

End tidal CO2
(arterial partial
pressure of CO2)
Gas
Exchange

Sensors +
Controllers

End tidal CO2 (arterial
partial pressure of CO2)

Minute
Ventilation

Minute
Ventilation

Sensors +
Controllers
Figure 4.1 Schematic of parametric models assumed for ventilatory control based on
results of Lai and Bruce(37). Parameters for these models were estimated using a
procedure described in the appendix. (a) Minute ventilation responses to changes in
inspired CO2 volume, which we refer to as close-loop response; (b) Minute ventilation
responses to changes in end tidal CO2 (arterial partial pressure of CO2), which we refer to
as open-loop response.

4.3

Baroreflex sensitivity estimation

We used sequence analysis method to estimate sensitivity of the baroreflex (26). First of
all, in beat by beat systolic blood pressure sequences, we identified those sequences
contained three or more monotonic increasing or decreasing beats. Secondly using one
beat delay in beat by beat RR interval, we identified those sequences in RR intervals
when blood pressure was increasing, RR interval also increased, and when blood pressure
was decreasing, RR interval also decreased. Once all these qualified sequences were
identified, we plotted all the points within a sequence on a plane with blood pressure as X
axis, RR interval as Y axis, and then estimated the slope of the sequences with least
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square error method for each qualified sequence. The average value of all the slopes was
used as an estimate of the sensitivity of baroreflex.
4.4

Spectrum, transfer function and coherence

Auto-spectrum was calculated using Welch’s method with 120-second window length,
50% overlap and Hamming window (68) . The auto-spectrum was normalized by the total
area under the auto-spectrum curve. Heart rate variability, blood pressure variability were
both calculated by the same method.
Transfer functions were estimated as the ratio of cross-spectrum of the input and output
of the signal to auto-spectrum of input signal
H (f) = Sxy(f) / Sxx(f)

(4.4.1)

Where Sxx(f) is the auto spectrum of input, Sxy(f) is cross spectrum between input and
output. The absolute value of H(f) is the gain of the transfer function.
Coherence was estimated by the following equation
C (f) = | Sxy(f) |2 / [ Sxx(f)*Syy(f) ]

(4.4.2)

Where Sxx(f) is the auto spectrum of input, Syy(f) is the auto spectrum of output and
Sxy(f) is the cross spectrum between input and output.
The auto-spectrum, transfer functions and coherencies were integrated within different
frequency ranges. The frequency band below 0.04Hz was considered very low frequency
(VLF) region, around 0.1Hz was considered as low frequency (LF) region and within
respiratory frequency region was considered high frequency (HF) region.
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4.5

Bispectra estimation

Bispectra were estimated by an approach similar to that described previously (56). As the
spectrum is defined as the Fourier transform of the auto-correlation, similarly the
bispectrum is defined as the 2-D Fourier transform of the third-order cumulant. The
bispectrum at frequency coordinate (f1, f2) is estimated as the average value of a triple
product of three discrete Fourier transforms at frequencies f1, f2 and f1+f2 as given in
equation (4.5.1).
Bxyz ( f1 , f 2 ) =

1
M

M

∑
k =1

x

S k ( f1 ) y S k ( f 2 ) z S k* ( f1 + f 2 ),

(4.5.1)

where * denotes conjugation, and

⎛ − j 2πnf ⎞
S ( f ) = ∑ X (n ) exp⎜
⎟.
⎝ N ⎠
n =1
N

x

(4.5.2)

Data were segmented into 120-second long segments with 50% overlap. A Hanning
window was used to reduce truncation effects. For all of the subjects who developed
pre-syncopal symptoms during Tilt control, the average duration before the onset of
symptoms was 13 minutes. To keep variances consistent for bispectra estimation, we
used data from first 13 minutes during Tilt Control for the group of subjects who did not
have any symptoms. In order to minimize the effects of differences in absolute
variabilities among subjects, we divided each bispectra by the largest value within that
bispectrum in the frequency region (0.04-0.3 Hz). All bispectra were normalized to
values between 0 and 1. To quantify the degree of phase coupling, bispectral surfaces
were integrated within different frequency bandwidths (four combinations of a low
frequency band (LF, 0.04-0.15Hz) and a high frequency band (HF, 0.15-0.3Hz)). These
four regions were named as regions I (f1: LF; f2: LF), II (f1: HF, f2: LF), III (f1: HF, f2: HF)
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and IV (f1: LF, f2: HF).We integrated frequencies up to 0.3 Hz in the high frequency band
because the bispectral powers for frequencies larger than 0.3 Hz were relatively small.
Since auto-bispectra are symmetrical along the diagonal, integration was conducted only
in regions I, II and III
We present an example here to illustrate how amplitude modulation type phenomenon
can lead to changes in bispectra, and thus produce a change in phase coupling (69).
Consider two signals x1(t) and x2(t).
x1(t) = sin(f1t+θ1)+ sin(f2t+θ2)+ 0.5cos((f1-f2)t+ θ3)+ 0.5cos((f1+f2)t+ θ4)
x2(t) = sin(f1t+θ1) + sin (f2t+θ2) + sin(f1t+θ1)* sin(f2t+θ2)
= sin (f1t+θ1) + sin (f2t+θ2) + 0.5cos ((f1-f2)t+ (θ1-θ2))- 0.5cos((f1+f2)t+ (θ1+ θ2)).
Where f1=0.28 Hz, f2=0.06 Hz, θ1, θ2, θ3, θ4 are random phases. Both x1 and x2 have
energies at four frequencies f1, f2, f1+f2 and f1-f2, but the difference between them is that
in x1(t) the phases are all random while in x2(t) the phase at frequency f1+f2 is θ1+ θ2, and
at frequency f1-f2 the phase is θ1-θ2 which is the result of modulation of f1 by f2.
Therefore, x2 is phase coupled at frequencies f1 and f2. x1(t) and x2(t) are shown in Figure
4.2(i) and (iii). Spectra of x1 and x2 are shown in Figure 4.2 (ii) and (iv). As seen from the
figure, both signals have same spectra although they have different phases. Bispectra
between these signals were estimated as described in equation 4.5.1 and shown in Figure
4.3 (a) and (b). The figure shows that the phase coupling in signal x2 is much larger than
that in signal x1. The figure also shows the symmetry that is present in the auto-bispectra.
There are two peaks seen in each half of the bispectra, one is at coordinate (f1, f2) while
the other is at (f1-f2, f2), because (f1-f2)+f2=f1 while (θ1-θ2)+θ2=θ1. Note that f1 is within
the high frequency region (0.15-0.30Hz) and f2 is within the low frequency region
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(0.04-0.15Hz), we selected signals in these frequency regions to simulate the type of
coupling observed in our study.
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Figure 4.2 Two test signals (x1 and x2) are shown in Figure 4.2(i) and (iii). Spectra of x1
and x2 are shown in Figure 4.2 (ii) and (iv). As seen from the figure, both signals have
same spectra although they have different phases.
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Figure 4.3 a

30

Figure 4.3 b

Figure 4.3 Bispectra for signals x1 (Figure 4.3a) and x2 (Figure 4.3b). The figure shows
that the phase coupling in signal x2 is much larger than that in signal x1. The figure also
shows the symmetry that is present in the auto-bispectra. There are two peaks seen in
each half of the bispectra, one is at coordinate (f1, f2) while the other is at (f1-f2, f2),
because (f1-f2)+f2=f1 while (θ1-θ2)+θ2=θ1.
4.6

Statistics

Differences between groups were compared using a t test assuming un-equal variances.
Differences between the stages were compared using paired t test. A p value of < 0.05
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was considered significant. Two-way ANOVA test (gender and stage are two factors)
was used to test whether gender had significant effects on mean cerebral blood flow.
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Chapter 5 Results

5.1 Experiment one
Six subjects developed pre-syncopal symptoms during Tilt Control. The other 24 subjects
did not have any presyncopal symptoms. Based on the outcome of tilt test, we divided
subjects into two groups; a Presyncopal and a Non-presyncopal group. One subject of the
Presyncopal group developed presyncopal symptoms early during Tilt Control, about 2
minutes after onset of Tilt Control. Since we did not have enough data during Tilt Control,
data from this subject were not used for the Tilt Control section. The results for the
presyncopal group during Tilt Control are from five subjects. The CBFV signal for two
subjects in the non-presyncopal group was not of quality comparable to that from other
subjects, therefore, CBFV signals from these two subjects were not used for calculating
the results related to CBFV.
5.1.1

Mean values

For the 24 non-presyncopal subjects, the mean values of their cardio-respiratory
parameters are shown in Table 5.1. Mean heart rate and blood pressure increased during
tilt compared to that during Supine Control. Relative to Supine Control, mean heart rate
decreased during Supine PRBS, likely a consequence of adaptation. There was no
difference in BP between Supine Control and Supine PRBS (Table 5.1). BP increased
during tilt compared to that during Supine Control. Neither peak cerebral blood flow nor
mean cerebral blood flow changed during Supine PRBS yet decreased during tilt relative
to Supine Control. As expected, V&E and Vt increased during both PRBS (Supine and Tilt)
compared with during Supine Control. V&E was also higher during Tilt Control relative
to that during Supine Control. Compared with Supine Control, ETCO2 increased during
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Supine PRBS and decreased by about 4 mm Hg during Tilt Control. There was no
increase in ETCO2 during Tilt PRBS compared with during Supine Control, likely due to
a decrease in mean ETCO2 produced by tilt.
Table 5.1 Mean values for cardio-respiratory parameters in the non-presyncopal subjects
(N=24). Values are shown as Mean ± SEM. *denotes the difference between Supine PRBS
and Supine Control is significant. † denotes the difference between Tilt PRBS and Supine
Control is significant. ‡ denotes the difference between Tilt Control and Supine Control is
significant.

Non-presyncopal

Supine

Supine

Tilt

Tilt

subjects (N=24)

Control

PRBS

PRBS

Control

Heart rate

74.1 ± 2.5

72.2* ± 2.5

87.2† ± 2.3

91.3‡ ± 2.4

MBP (mmHg)

90.9 ± 2.5

91.9 ± 2.3

102.6† ± 3.5

105.7‡ ± 4.2

CBFP (cm/s)

84.9 ± 3.5

85.6 ± 3.7

73.4† ± 3.2

72.9‡ ± 2.8

CBFM (cm/s)

73.3 ± 3.2

74.3 ± 3.3

64.7† ± 2.9

64.5‡ ± 2.4

Vt ( ml)

582.6 ± 39.9

630.6* ± 37.1

686.3† ± 50.0

614.4 ± 31.9

Resp rate

13.6 ± 0.5

13.9 ± 0.6

14.2 ± 0.6

14.2 ± 0.6

V&E ( L/min)

7.63 ± 0.4

8.62* ± 0.5

10.0† ± 0.5

8.47‡ ± 0.4

ETCO2( mmHg)

46.9 ± 0.9

49.4* ± 0.9

47.4 ± 0.9

42.9‡ ± 1.0

(beats/min)

(breaths/min)
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As shown in Table 5.2, the mean value changes in presyncopal subjects were similar to
those of non-presyncopal subjects. Some changes are not significant, which might relate
to the limited number of subjects in this group.

Table 5.2 Mean values for cardio-respiratory parameters in the presyncopal subjects
(N=5). Values are shown as Mean ± SEM. * denotes the difference between Supine PRBS
and Supine Control is significant. † denotes the difference between Tilt PRBS and Supine
Control is significant. ‡ denotes the difference between Tilt Control and Supine Control is
significant. s denotes the difference between non-presyncopal and presyncopal group is
significant.
Presyncopal

Supine

Supine

Tilt

Tilt

subjects (N=5)

Control

PRBS

PRBS

Control

Heart rate

69.1 ± 4.3

68.4 ± 3.7

90.5† ± 5.8

95.7‡ ± 4.0

MBP (mmHg)

86.9 s ± 2.6

88.8 s ± 1.5

91.2 s ± 2.0

92.9 s ± 1.6

CBFP (cm/s)

97.2 ± 6.7

97.4 ± 5.7

87.7†, s ± 6.0

83.3‡, s ± 4.6

CBFM (cm/s)

86.1 s ± 5.7

86.4 s ± 5.0

79.7†,s ± 5.2

75.6‡,s ± 4.2

Vt ( ml)

726.6 ± 99.6

768.2 s ± 33.9

909.8†,s ± 78.5

780.3 ± 113.3

Resp rate

12.5 ± 1.3

13.7 ± 0.5

13.4 ± 1.0

13.4 ± 1.3

V&E ( L/min)

8.7 s ± 0.4

10.6*,s ± 0.4

12.0†,s ± 0.52

10.1 ± 1.0

ETCO2( mmHg)

44.9 ± 2.9

47.8* ± 3.0

44.7 ± 3.0

38.5‡ ± 2.8

(beats/min)

(breaths/min)
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5.1.2

Impulse responses of ventilatory control of CO2

To determine orthostatic modification of ventilatory sensitivity, we compared open and
closed loop ventilatory responses to CO2 disturbances between Supine PRBS and Tilt
PRBS for both presyncopal and non-presyncopal group. The typical model parameters for
open loop non-presyncopal group were nn= [1 2 2 1 2]. Figure 5.1a shows ETCO2 in
one subject during the four stages of the study. As expected there was an increase in
ETCO2 during Supine PRBS and Tilt PRBS. Figure 5.1b shows V&E across the study
(dashed line) and V&E predicted by the fitted model (solid line). The overlap between the
two traces shows that the model predicted changes in ventilation acceptably.
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Figure 5.1 The top panel (a) shows an example of end tidal CO2 in a non-presyncopal
subject across the four states of the study, Supine control, Supine PRBS, Tilt PRBS
and Tilt control. The bottom panel (b) shows change in ventilation (dashed) during
the four states and predicted change in ventilation using the fitted model (solid). The
overlap between the two traces shows that the model predicted changes in ventilation
acceptably.
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From the model, we computed an impulse response of the ventilatory control system to a
single breath perturbation in ETCO2 of 1 mmHg. Figure 5.2 shows open loop impulse
responses in one typical subject from the non-presyncopal group during Supine PRBS
(thin line) and Tilt PRBS (thick line). The impulse response during tilt showed an
increase in peak values and decrease in decay time (time for the response to decrease by
50%) relative to supine. We computed gains, peak values and decay times from the
impulse responses as indexes of sensitivity of the control system. As shown in Figure 5.3,
the control system gain (integral of the impulse response) was significantly higher
(p<0.005) during tilt (0.73 ± 0.10 L/Min/mmHg) compared with that during supine
(0.46 ± 0.08 L/Min/mmHg). Peak values were also higher (p<0.05) during tilt (0.10 ±
0.01 L/Min/mmHg) relative to supine (0.06 ± 0.01 L/Min/mmHg). Decay times of the
responses were shorter during tilt (43.6 ± 4.99 seconds) relative to that during supine
(53.4 ± 10.1 seconds), this difference, however, was not significant. The closed loop
responses did not show any differences between supine and tilt. There were no significant
differences between presyncopal and non-presyncopal subjects in impulse responses.
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Figure 5.2 Open loop impulse responses in a non-presyncopal subject during Supine
PRBS (thin line) and Tilt PRBS (thick line). The responses show an increase in peak
value and decrease in decay time (time for the response to decrease by 50%) during
tilt relative to that during supine.
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Figure 5.3 Integrals (a), peak values (b) and 50 % amplitude decay time (c) for
non-presyncopal group average (N=24) open loop impulse responses. The responses
show that integral of the impulse response and peak values were larger in tilt than in
supine (p < 0.05). The impulse responses decayed faster in tilt than supine (c) but the
difference was not significant.
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5.1.3 Transfer function between end tidal CO2 and ventilation

To verify and to complement changes in ventilatory responses that we obtained using
parametric estimates, we used a non-parametric transfer function estimate. Figure 5.4
showed the average transfer function magnitude between ETCO2 and V&E from
non-presyncopal subjects (N=24). The transfer functions showed higher magnitude at
most frequencies below the Nyquist frequency of 0.12 Hz (Since the average respiratory
rate is about 14 breaths/min, the average breathing frequency is 0.24 Hz and the Nyquist
frequency is half of the breathing frequency). We integrated the transfer function
magnitudes over all frequencies between 0 and 0.12 Hz to quantify an index of
ventilatory response. The average integrated transfer function values during Supine
PRBS (0.22 ± 0.02 L/min/mmHg) were larger than during Tilt PRBS (0.29 ± 0.02
L/min/mmHg) (Mean±SEM) (p < 0.05). The figure shows that the difference in transfer
function magnitudes between Supine and Tilt was more pronounced in the frequency
region between 0.08 and 0.1 Hz. The average of the transfer functions magnitude within
this frequency region was also significantly higher (p < 0.01) during tilt than supine. Note
that the estimates for near zero (DC) frequencies are unreliable due to removal of mean
during computation of the transfer functions.
Using a similar method, we estimated the transfer function between ETCO2 and V&E for
the presyncopal subjects (N=6) during Supine PRBS and Tilt PRBS. Unlike
non-presyncopal group, there were no significant differences between supine and tilt for
presyncopal group. When comparing between groups, as shown in Figure 5.5, it is
obvious that at most frequencies the mean value for the transfer function gain is higher
for presyncopal subjects than non-presyncopal subjects during supine. Integrated transfer
function gain in the frequency region 0.08-0.11Hz were higher for presyncopal subjects
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than non-presyncopal subjects during supine (p<0.05). There were no significant
differences between groups during tilt. The presyncopal group started with a higher gain
and did not increase further during tilt; while the non-presyncopal group started with a
lower gain, then the gain was enhanced during tilt.
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Figure 5.4 Non-presyncopal group average (N=24) transfer function gain between
ETCO2 and V&E during Supine PRBS (dashed) and Tilt PRBS (solid). Note that for
almost all frequencies the gain was larger in tilt than in supine. Differences in gain
were largest in a frequency region approximately between 0.08 and 0.1 Hz. Note that
the estimates for near zero (DC) frequencies are unreliable due to removal of mean
during computation of the transfer functions.
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Figure 5.5 Average transfer function gains between ETCO2 and V&E

for

non-presyncopal group (dashed) and presyncopal group (solid) during Supine
PRBS. Note that for almost all frequencies the gain was larger in presyncopal group
than in non-presyncopal group.
To show that PRBS widens the input spectrum, in our case the spectrum of ETCO2, we
include Figure 5.6. As shown in Figure 5.6, during PRBS stimulation (pink), the ETCO2
spectrum had more power within a larger frequency range between 0 and 0.15 Hz than
during Supine Control (blue). These results show that PRBS input did widen the input
spectrum as expected.
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Figure 5.6 Power spectrum for ETCO2 during Supine PRBS (pink) and Supine Control
(blue).
5.1.4 Baroreflex sensitivity, heart rate and blood pressure variability
In non-presyncopal subjects, baroreflex sensitivity increased from 5.5 msec/mmHg
during supine to 17.6 msec/mmHg during tilt (p<0.001). Similarly, in pre-syncopal
subjects, baroreflex sensitivity increased from 6.5 during supine to 21.8 msec/mmHg
during tilt (p=0.01)
Figure 5.7 shows the averaged RR interval spectra for non-presyncopal subjects (N=24)
(a) and for presyncopal subjects (N=6) (b) during the four stages of our study. The
distribution of power seen in these spectra reveals frequency regions where these signals
oscillated. We note that spectra from pre-syncopal group show more pronounced peaks in
very low, low and high frequency regions relative to those seen in spectra from the
non-presyncopal group. It is possible that variations in intrinsic breathing frequencies
among the larger pool in non-presyncopal group averaged the power over wider
frequency range.
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Figure 5.7 b
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Figure 5.7 The average heart rate variability for non-presyncopal subjects (N=24) (a) and
for presyncopal subjects (N=6) (b) during the four stages of our study.(i) Supine Control
(ii) Supine PRBS (iii) Tilt PRBS (iv) Tilt Control.
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As an index of parasympathetic activity, we computed respiratory synchronous heart rate
variability for the non-presyncopal subjects, which decreased during tilt from 1.08 to 0.47
AU, p < 0.01, a 57 % decrease which was comparable to those reported previously, i.e.
60% and 77% (Patwardhan et al.(54) and Laitinen et al (38)).
Figure 5.8 shows the average of MBP spectra during Supine Control (dashed) and Tilt
Control (solid) for non-presyncopal subjects. As expected, blood pressure oscillations
within the LF region centered at 0.1 Hz increased during tilt (p < 0.01).
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Figure 5.8 Average (N=24) of mean blood pressure variability during Supine
Control (dashed) and Tilt Control (solid) for non-presyncopal subjects. As
expected, blood pressure oscillations within the LF region centered at 0.1 Hz
increased during tilt (p < 0.01).
5.1.5

Gender-related differences in non-presyncopal subjects

We selected age-matched 10 male and 10 female subjects from the non-presyncopal
group. The mean values of CBFM, heart rate, MBP, ventilation and ETCO2 are listed
(Mean ± SEM) in tables 5.3 (Men) and 5.4 (Women) for the four stages of the study.
Results from two-way ANOVA test shows that the factor of gender had significant
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effects on CBFM (p<0.05). Women had higher CBFM than men (a difference of almost
10cm/s) during Supine Control and Supine PRBS. During Tilt PRBS, CBFM for both
groups was almost the same, while during Tilt Control, the mean value for women was
higher, but the difference (5 cm/s) was smaller compared with that observed during the
supine position. For both groups, CBFM had a small but significant increase during
Supine PRBS compared with Supine Control and significant decrease during tilt. Heart
rate, blood pressure and ventilation were increased during tilt for both groups, as
expected. ETCO2 was increased during Supine PRBS and decreased during Tilt Control
for both groups (68).
Table 5.3 Mean values for male subjects (N=10). a significant difference between Supine
PRBS and Supine Control;

b

significant difference between Tilt PRBS and Supine

Control; c significant difference between Tilt Control and Supine Control.

Male
CBFM
(cm/s)
Heart Rate
(beats/min)
MBP
(mmHg)
Ventilation
(L/Min)
ETCO2
(mmHg)

Supine Control
67.0 ± 4.5

Supine PRBS
68.8 a ± 5.1

Tilt PRBS
66.4 ± 4.8

Tilt Control
62.5 c ± 4.5

74.6 ± 4.7

72.2 a ± 4.5

89.9 b ± 4.0

94.5 c ± 4.1

96.1 ± 3.7

95.1 ± 3.2

100.6 b ± 4.2

104.3 c ± 4.2

7.9 ± 0.7

8.4 ± 0.8

9.7 b ± 0.9

8.5 ± 0.7

48.2 ± 1.7

50.8 a ± 1.5

48.7 ± 1.1

44.3 c ± 1.7
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Table 5.4 Mean values for female subjects (N=10).

a

significant difference between

Supine PRBS and Supine Control; b significant difference between Tilt PRBS and Supine
Control; c significant difference between Tilt Control and Supine Control;
* significant difference between men and women.
Female
CBFM
(cm/s)
Heart Rate
(beats/min)
MBP
(mmHg)
Ventilation
(L/Min)
ETCO2
(mmHg)

Supine Control
76.7* ± 3.5
(*p=0.07)
72.1 ± 3.5

Supine PRBS
78.3*,a ± 3.6
(*p=0.07)
70.5 ± 3.5

Tilt PRBS
65.6 b ± 3.9

Tilt Control
67.5 c ± 2.99

82.9 b ± 3.5

87.0 c ± 3.66

85.4 ± 4.0

89.4 ± 3.3

97.8 b ± 3.6

100.0 c ± 4.2

7.6 ± 0.5

8.9a ± 0.7

10.0 b ± 0.9

8.3 c ± 0.5

46.2 ± 1.2

48.8a ± 1.2

46.9 ± 1.3

42.1c ± 1.2

Figure 5.9 shows averaged coherencies between mean blood pressure (MBP) and mean
cerebral blood flow (CBFM) during Supine Control for men (thin line) and women (thick
line). Integrated coherence within 0.03-0.10 Hz and 0.22-0.31 Hz showed that women
had significantly higher coherence than men during Supine Control (p=0.05 and 0.01). As
shown in Figure 5.10, transfer function gains were higher in women (thick line) than men
(thin line) in frequency regions 0.03-0.14 Hz and 0.22-0.31 Hz during Supine Control.
The differences in integrated gains within these regions were significant (p=0.0045 and
0.0015).
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Figure 5.9 Averaged coherencies between mean blood pressure (MBP) and mean cerebral
blood flow (CBFM) in female (thick line) and male (thin line) subjects during Supine
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Figure 5.10 Averaged transfer function gains between mean blood pressure (MBP) and
mean cerebral blood flow (CBFM) in female (thick line) and male subjects (thin line)
during Supine Control.
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As shown in Figure 5.11, men had significantly higher coherence than women during Tilt
PRBS between 0.05-0.28 Hz (p=0.0013). As shown in Figure 5.12, between 0.05-0.26 Hz
men had significantly higher coherence than women during Tilt Control (p=0.016). The
transfer function gain for men during Tilt PRBS tended to be larger than women but the
difference was not significant. The transfer function gain in Tilt Control also did not
show significant differences between women and men.
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Figure 5.11 Average coherencies between mean blood pressure (MBP) and mean cerebral
blood flow (CBFM) in women (thick line) and men (thin line) during Tilt PRBS.
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Figure 5.12 Average coherencies between mean blood pressure (MBP) and mean cerebral
blood flow (CBFM) in women (thick line) and men (thin line) during Tilt Control.
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5.1.6 Bispectrum estimation

Figure 5.13 shows an example of the normalized auto-bispectrum calculated from RR
intervals in one non-presyncopal subject during the four sections of study. The
auto-bispectra are symmetric around the diagonal (f1=f2), therefore only half of the
bispectral surfaces are shown in the figure; the other half is shown as zero. The figure
shows concentration of power at low frequencies, as expected from the nature of RR
interval variability. Changes in the phase coupling during PRBS are also evident: phase
coupling is seen at relatively higher frequencies during Supine PRBS (panel ii) but is
concentrated at very low frequencies during Tilt PRBS (panel iii).
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(i)

(ii)

(iv)

(iii)

Figure 5.13 Normalized auto-bispectra for RR intervals from one typical subject in the
non-presyncopal group during each stage of the study (i-Supine Control; ii-Supine PRBS;
iii-Tilt PRBS; iv-Tilt Control). The auto-bispectra are symmetric around the diagonal
(f1=f2), therefore, only half of the bispectral surfaces are shown in the four panels. The
figure shows concentration of power at very low frequencies. Changes in the phase
coupling during PRBS are also evident, at higher frequencies during Supine PRBS (panel
ii) and concentration of power at very low frequencies during Tilt PRBS (panel iii).
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To quantify the degree of phase coupling between frequencies, we integrated bispectra
within different frequency regions defined by frequencies ranges (f1 and f2). The
integrated bispectral values were then compared for statistically significant differences as
follows: The effects of orthostatic and chemoreflex modulation of phase coupling were
compared within the non-presyncopal and the presyncopal groups across all four sections
of the study (Tables 5.5 and 5.6). To determine changes in phase coupling prior to the
onset of presyncope, a between-groups comparison was made during each section of the
study (Table 5.6).
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Table 5.5 Integrated bispectra for the non-presyncopal subjects (N=24). † Significant
difference between Supine PRBS and Supine Control; ‡ Significant difference between
Tilt PRBS and Supine Control; * Significant difference between Tilt Control and Supine
Control.
RR
I
II
III
SBP
I
II
III
RR-SBP
I
II
III
IV
RR-Vt
I
II
III
IV
CBFM-ETCO2
I
II
III
IV
CBFM-SBP
I
II
III
IV

Supine Control Supine PRBS
Tilt PRBS
Tilt Control
†
30.89±4.7
21.13*±3.09
36.87±4.92
47.2 ±5.5
28.47‡±6.2
14.14*±2.6
41.03±6.21
64.3†±8.92
8.454‡±2.2
3.457*±0.78
15.15±2.99
25†±4.93
12.35±1.8

12.2±1.94

33.67‡±4.1

32.54*±3.95

8.909±1.7
2.278±0.5

7.74±1.55
1.96±0.52

29.88‡±7.5
10.81‡±4.4

20.9*±3.07
5.04*4±0.8

62.36±6.92

75.1†±6.62

70.93±7.4

51.93±5.35

41.05±5.72
15.02±2.93
24.33±3.44

60.3†±7.92
23.3†±4.61
33.2†±5.1

34.2±5.4
15.53±3.4
28.9±4.9

20.04*±3.65
7.849*±1.64
17.64*±2.9

44.95±5.78
26.98±3.98
5.739±1.18
9.889±1.3

60.7†±7.87
48†±8.21
11.2†±2.84
16.5†±2.81

57.89‡±6.7
26.51±4.2
5.757±1
12.41‡±2

41.5±6.06
15.32*±2.72
3.52±0.72
8.954±1.71

13.53±2.1
5.85±0.83
1.37±0.19
3.955±0.79

41.3†±5.67
16.1†±2.53
3.73†±0.58
11.5†±1.49

62.45‡±6.5
26.94‡±3.5
6.016‡±0.8
17.16‡±2.6

25.89*±4.9
11.64*±2.84
2.648*±0.59
6.765*±1.32

23.63±3.5
10.66±1.74
4.276±0.82
9.757±1.55

34.5†±5.56
13.2†±2.28
5.35±0.98
14.2†±2.45

76.45‡±5.8
29.57‡±2.5
14.15‡±1.7
34.56‡±4.7

46.15*±5.39
19.15*±2.19
7.465*±0.94
16.94*±1.68
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Table 5.6 Integrated bispectra for presyncopal subjects (N=6). † Significant difference
between Supine PRBS and Supine Control; ‡ Significant difference between Tilt PRBS
and Supine Control; * Significant difference between Tilt Control and Supine Control; a
Significant difference between non-presyncopal and presyncopal subjects.

RR
I
II
III
SBP
I
II
III
RR-SBP
I
II
III
IV
RR-Vt
I
II
III
IV
CBFM-ETCO2
I
II
III
IV
CBFM-SBP
I
II
III
IV

Supine Control
22.08±7.19

Supine PRBS
27.48 a ±8.78

Tilt PRBS
16.06 a ±5.05

Tilt Control
14.4±5.36
5.29a,*±1.56
(*p=0.06)
1.01a,*±0.26
(*p=0.06)

24±8.18

39.3±12.4

13.53 a ±5.51

11.51±5.31

20.62†±6.65

5.82±3.46

14.02±3.93

11.67±2.5

45.71‡±11.6

41.93*±5.50

6.16±1.65
1.34±0.47

7.67±2.22
1.41±0.41

40.89‡±17.4
13.68±7.04

18.67*±4.77
2.98 a, *±0.81

40.3 a±9.37

46.97 a±13.1

48.26±14

35.19±9.21

26.48±6.47

46.17±15.4

24.8±11.2

9.03±2.62
12.12 a±2.30

17.05†±4.63
18.41 a±4.83

15.33±9.39
19.8±9.32

8.72 a,*±1.93
(*p=0.06)
2.44 a, *±0.44
7.09a±1.81

32.9±10.01
19.77±5.77
4.28±1.27
7.31±2.48

53.99±16.4
46.61†±15.8
10.34†±3.41
11.56±3.33

53.3±13.8
25.01±9.05
7.011±4.01
9.9±3.81

29.99±4.17
8.00 a, *±1.59
1.88 a± 0.31
5.04 a± 0.89

8.43±2.52
4.16±1.59
1.12±0.5
2.68±0.99

28.1†±9.37
16.17†±6.48
4.10±2.26
8.94†±2.54

44.24‡±10.3
16.85 a, ‡±4.42
3.28 a, ‡±0.84
10.05 a, ‡±2.55

33.48±13.16
11.4±4.90
2.38±1.05
7.43±3.41

27.5±11.26
14.38±6.72
5.42±2.44
10.26±4.26

30.57±10.1
18.19†±7.09
9.66±5.97
14.86†±5.13

61.04‡±15.2
20.05±5.04
11.38‡±4.62
23.06±7.02

66.04 a, *±6.27
19.19±1.14
5.95±0.48
16.21±3.13
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Figure 5.14 shows contour plots of group averaged RR interval auto-bispectra. The
non-presyncopal group’s averaged RR interval bispectra are shown in Figure 5.14 (a),
and those from the presyncopal group are in 5.14 (b). There was an enhanced coupling of
frequencies less than 0.1 Hz with those greater than 0.1 Hz during Supine PRBS for both
groups which probably reflected altered chemoreflex control. The contours in panel iii
and iv show the orthostatic effects. As given in Table 5.5, in non-presyncopal group in all
frequency regions phase coupling increased during Supine PRBS while phase coupling
decreased during Tilt PRBS and Tilt Control, relative to Supine Control. As given in
Table 5.6, we observed a similar pattern of change in the presyncopal group as in the
non-presyncopal group. The increase in phase coupling during Supine PRBS in frequency
region III was significant and the decreases in phase coupling during Tilt Control, within
frequency regions II and III were not significant at our threshold of p=0.05 (they were
marginally significant with p=0.06). Comparison between groups showed that phase
coupling in RR interval was smaller in the presyncopal group than the non-presyncopal
group during Supine PRBS within frequency region I, during Tilt PRBS within regions I
and II, and during Tilt Control within frequency regions II and III.
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Figure 5.14 b
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Figure 5.14 Contour plots of group averaged RR interval auto-bispectra (i-Supine Control;
ii-Supine PRBS; iii-Tilt PRBS; iv-Tilt Control). (a) shows the averaged (N=24) bispectra
for the non-presyncopal group. The contours in panel iii and iv show the orthostatic
effects. (b) shows the averaged (N=6) bispectra of the presyncopal group. As shown in
panel (iv) during Tilt Control, there was a marked reduction in the spread of contours
relative to that during Tilt PRBS (panel iii).

Figure 5.15 shows contour plots of group averaged Systolic blood pressure (SBP)
auto-bispectra in a format similar to that in Figure 5.14. The non-presyncopal group’s
averaged SBP bispectra are shown in Figure 5.15 (a), and those from the presyncopal
group are in 5.15 (b). Figure 5.15 shows that relative to RR intervals, the phase
coupling within SBP was confined to lower frequencies. Comparison between the
contours in panels i, ii with iii and iv of the figures show that phase coupling in both
groups increased significantly during tilt within almost all the frequency regions (except
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for presyncopal subjects during Tilt PRBS within region III) . Comparison between
groups showed, the phase coupling was lower for the pre-syncopal than for the
non-presyncopal group during Tilt Control within region III (0.15-0.30, 0.15-0.30Hz).
Figure 5.15 a
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Figure 5.15 b

(i)

(ii)

(iv)

(iii)
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Figure 5.15 Contour plots of group averaged systolic blood pressure (SBP) auto-bispectra
(i-Supine Control; ii-Supine PRBS; iii-Tilt PRBS; iv-Tilt Control). Figure 5.15 (a) shows
the averaged (N=24) bispectra for the non-presyncopal group. Comparison between the
contours in panels i, ii with iii and iv of the figure show that tilt increased phase coupling.
Figure 5.15 (b) shows the averaged (N=6) bispectrum for the presyncopal group. There
was a noticeable increase in the spread of contours in presyncopal group relative to that
in the non-presyncopal group in all stages.

The cross-bispectra are not symmetric, therefore, the bispectra were estimated over the
entire frequency range, i.e. 0.04-0.3, 0.04-0.3 Hz. The group averaged bispectra between
RR interval and SBP are shown in Figure 5.16. It is obvious that the low frequencies
were more modulated by high frequency during Supine PRBS for presyncopal group than
non-presyncopal group. As shown in Table 5.5 and Table 5.6, for both groups, during
Supine PRBS, phase coupling between RR interval and SBP increased in all the
frequency regions, while during Tilt Control, phase coupling decreased. Comparisons
between groups showed that the presyncopal group had a lower degree of coupling than
non-presyncopal group during Supine Control and Supine PRBS in region I and IV,
during Tilt Control in region II, III and IV.
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Figure 5.16 a

(ii)

(i)

(iv)

(iii)
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Figure 5.16 b

(i)

(ii)

(iv)

(iii)

Figure 5.16 Contour plots of group averaged cross-bispectra between RR interval and
systolic blood pressure (RR-SBP) (i-Supine Control; ii-Supine PRBS; iii-Tilt PRBS;
iv-Tilt Control). Figure 5.16 (a) shows the averaged (N=24) bispectra for the
non-presyncopal group. Figure 5.16 (b) shows the averaged (N=6) bispectrum for the
presyncopal group.
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To investigate cardio-respiratory interactions, we calculated cross-bispectra between
RR-interval and Tidal volume, the results of which are shown in Figure 5.17. During
Supine PRBS, we observed increased phase coupling between RR interval and Tidal
volume for both groups within all the frequency regions (except for presyncopal subjects
within region I and IV). For both groups during Tilt control in region II, modulation of
higher frequencies in RR interval (f1: 0.15-0.3Hz) by lower frequencies in Tidal volume
(f2: 0.04-0.15Hz) decreased. During Tilt PRBS, we observed enhanced phase coupling in
region I and IV for the non-presyncopal subjects. During Tilt Control, the phase coupling
was lower in pre-syncopal than in non-presyncopal group in frequency region II, III and
IV.
Figure 5.17 a

(i)

(ii)

(iv)

(iii)
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Figure 5.17 b

(i)

(ii)

(iv)

(iii)

Figure 5.17 Contour plots of group averaged cross-bispectra between RR interval and
tidal volume (RR-Vt) (i-Supine Control; ii-Supine PRBS; iii-Tilt PRBS; iv-Tilt Control).
Figure 5.17 (a) shows the averaged (N=24) bispectra for the non-presyncopal group.
Figure 5.17 (b) shows the averaged (N=6) bispectrum for the presyncopal group.
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As shown in Figure 5.18, we calculated cross-bispectra between CBFV and ETCO2 to
investigate the effects of arterial partial pressure of CO2 on CBFV. Cross-bispectra
between CBFV and ETCO2 showed that, in non-presyncopal subjects (Table 5.5), relative
to Supine Control, phase coupling increased during Supine PRBS, Tilt PRBS and Tilt
Control in all frequency regions. In presyncopal group, the changes in phase coupling
showed a similar trend to changes in the non-presyncopal group (within some frequency
regions the changes were not significant). Between-groups comparison showed that the
presyncopal group had a lower phase coupling compared to non-presyncopal group
during Tilt PRBS in frequency regions II, III and IV.
Figure 5.18 a

(i)

(ii)

(iv)

(iii)
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Figure 5.18 b

(i)

(ii)

(iv)

(iii)

Figure 5.18 Contour plots of group averaged cross-bispectra between CBFM and ETCO2
volume (CBFM-ETCO2) (i-Supine Control; ii-Supine PRBS; iii-Tilt PRBS; iv-Tilt
Control). Figure 5.18 (a) shows the averaged (N=24) bispectra for the non-presyncopal
group. Figure 5.18 (b) shows the averaged (N=6) bispectra for the presyncopal group.
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In order to determine changes in cerebral autoregulation, we calculated cross-bispectrum
between CBFV and SBP as shown in Figure 5.19. Relative to Supine Control, phase
coupling increased in the non-presyncopal group during Supine PRBS, Tilt PRBS and
Tilt Control in all frequency regions (Table 5.5). Changes in the presyncopal group were
similar but the difference was not significant in some frequency regions. Comparisons
between groups showed that during Tilt Control pre-syncopal subjects had higher phase
coupling than non-presyncopal subjects within frequency region I (Table 5.6).
Figure 5.19 a

(i)

(ii)

(iv)

(iii)
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Figure 5.19 b

(i)

(ii)

(iv)

(iii)

Figure 5.19 Contour plots of group averaged cross-bispectra between CBFM and SBP
(CBFM-SBP) (i-Supine Control; ii-Supine PRBS; iii-Tilt PRBS; iv-Tilt Control). Figure
5.19(a) shows the averaged (N=24) bispectra for the non-presyncopal group. Figure 5.19
(b) shows the averaged (N=6) bispectra for the presyncopal group.
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5.2

Experiment two (effects of hypocapnia on cerebral autoregulation)

Two out of the eighteen subjects developed presyncopal symptoms during stage 4 of
experiment two. Both of them were in treatment group. Since the number of subjects
who developed presyncope was not adequate to perform any statistical analysis, we used
data from the 16 non-presyncopal subjects to report results from experiment two. Eight of
these subjects were in the treatment group and the other eight were in the control group.

5.2.1 Mean values
Mean values of cardio-respiratory parameters are shown for treatment group (Table 5.7)
and control group (Table 5.8) during all four stages of our study. As expected, ETCO2
decreased significantly (47 to 36.6 mmHg) during stage 4 of the study compared with
stage 1 for treatment group. While ETCO2 for control group did not change (48 to 48.4
mmHg) during stage 4 compared with stage 1. Blood pressure did not change for both
groups. During tilt (stage 3 and 4), subjects in both groups increased their heart rate.
CBFM in both groups increased during stage 2 and decreased during stage 4 compared
with stage 1. Tidal volume, ventilation and respiratory rate were almost same for both
groups in stage 3 and 4. Comparison between groups showed that during stage 4,
treatment group had significant lower ETCO2 level than control group.
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Table 5.7 Mean values for treatment group in experiment two (N=8). *Significant
difference between stage 2 and stage 1; †Significant difference between stage 3 and stage
1; ‡Significant difference between stage 4 and stage 1; s Significant difference between
treatment and control group.
Mean values of:
Stage 1
Heart
rate 69.8 ± 4.0
(beats/min)

Stage 2
70.9* ± 4.3

Stage 3
85.8† ± 4.6

Stage 4
92.1‡ ± 5.4

BPMCA (mmHg)

77.3 ± 4.0

79.5 ± 4.76

82.4 ± 7.45

86.5 ± 6.5

CBFP (cm/s)

85.4 ± 6.0

89.2 ± 6.7

80.5 ± 5.5

70.8 ± 5.1

CBFM (cm/s)

76.7 ± 5.1

80.3* ± 5.9

73.6 ± 4.8

65.5‡ ± 4.4

Vt (ml)

659 ± 42.7

925.5* ± 66.9

936† ± 59.1

900‡ ± 64.2

Resp
rate 11.7 ± 0.8
(breaths/min)
7.6 ± 0.2
V&E (L/min)

12.5* ± 0.6

12.8† ± 0.7

12.1‡ ± 0.6

11.5* ± 0.8

11.7† ± 0.3

11.0‡ ± 0.5

ETCO2 (mmHg) 47 ± 2.1

48.1 ± 1.7

45.5 ± 1.5

36.6‡,s ± 2.1

73

Table 5.8 Mean values for control group in experiment two (N=8). *Significant
difference between stage 2 and stage 1; †Significant differences between stage 3 and stage
1; ‡Significant difference between stage 4 and stage 1.
Mean values of:
Heart rate
(beats/min)

Stage 1
66.4 ± 5.2

Stage 2
67.7 ± 6.6

Stage 3
82.0† ± 6.1

Stage 4
87.0‡ ± 7.0

BPMCA (mmHg)

70.6 ± 5.2

74.4 ± 6.8

74.6 ± 5.9

78.3 ± 5.0

CBFP (cm/s)

90.0 ± 3.1

96.2* ± 2.9

80.2 ± 3.4

76.3‡ ± 2.6

CBFM (cm/s)

78.7 ± 2.5

84.9* ± 2.6

72.8 ± 2.8

69.4‡ ± 2.0

Vt (ml)

650 ± 47.2

882.1* ± 51.5

924† ± 66.6

940‡ ± 73.2

Resp rate
(breaths/min)

13.3 ± 1.2

13.2 ± 1.0

13.4 ± 1.0

13.2 ± 1.0

8.3 ± 0.5

10.6* ± 0.6

12.1† ± 0.7

12.1‡ ± 0.6

48 ± 1.7

51.9* ± 1.8

48.5 ± 2.0

48.4 ± 1.9

V&E (L/min)
ETCO2 (mmHg)
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Ventilation and end tidal CO2 across the four stages of our study from one typical subject
in the treatment group is shown in Figure 5.20. Top panel shows ventilation. Bottom
panel shows end tidal CO2. It is clear that from these figures, end tidal CO2 decreased
while ventilation was relatively constant which means the subject had hypocapnia with
minor changes in the ventilation.
The coefficients of variation were calculated as the ratio of variation in the signals to
mean values of the signals, which is an indicator of relative changes in the signals. A
lower value of coefficient of variation means relatively less variation. The coefficients of
variation for tidal volume in treatment group decreased from 0.26 ± 0.04 (stage 1,
spontaneous breathing) to 0.16 ± 0.04 (stage 4, controlled breathing). The coefficients of
variation of ventilation and respiratory rate in treatment group decreased from 0.004 to
0.002 and from 0.22 ± 0.04 to 0.12 ± 0.03 (Mean ± SEM). We can see the coefficients of
variation for tidal volume, ventilation and respiratory rate decreased during controlled
breathing for treatment group which means the variation for those parameters during
controlled breathing were less.
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Figure 5.20 Ventilation (Top) and ETCO2 (Bottom) from one typical subject in the
treatment group. It is clear from these figures that the subject’s ETCO2 decreased while
his ventilation was almost constant which means the subject had hypocapnia with minor
changes in the ventilation.
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Similar to Figure 5.20, ventilation (Top) and ETCO2 (bottom) from one subject in the
control group is shown in Figure 5.21. As shown in the figure, the subject controlled the
ventilation and the ETCO2 level was maintained. The coefficients of variation for tidal
volume in control group decreased from 0.31 ± 0.04 (stage 1, spontaneous breathing) to
0.18 ± 0.04 (stage 4, controlled breathing). The coefficients of variation of ventilation and
respiratory rate in control group decreased from 0.003 to 0.002 and from 0.19 ± 0.01 to
0.14 ± 0.02 (Mean ± SEM).

Figure 5.21 Ventilation (Top) and ETCO2 (bottom) from one typical subject in the control
group. As seen from this figure, the subject controlled the ventilation yet the CO2 level
was normal.
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Figure 5.22 Target pattern (pink) and instantaneous tidal volume (blue) from one subject
during voluntarily controlled breathing.

Figure 5.22 shows how the subject followed the generated pattern. The red curve is the
target pattern generated by our Labview® program and the blue curve is the subjects’
instantaneous tidal volume calculated as the integrated airflow during each breath and
was reset to zero after each breath. From this figure, we can see the subject followed the
pattern acceptably.

5.2.2

Auto-spectra of CBFM, BPMCA and CVR

The averaged auto-spectra of CBFM, BP MCA and CVR are shown in Figure 5.23. As
shown in Figure 5.23, low frequency power is concentrated within region 0.04-0.15Hz,
high (respiratory) frequency power is concentrated within region 0.15-0.32Hz, therefore
the auto-spectra of CBFM, BPMCA, and CVR were integrated within LF(0.04-0.15Hz) and
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HF (0.15-0.32Hz) frequency regions; then the integrated values were compared for
statistically significant differences as follows: To determine how hypocapnia will affect
CA, a between-group comparison was performed during the stage 4 of the study. Power
spectra during stage 4 were compared with that during stage 1 (baseline data) within each
group. The results are shown in Table 5.9.
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Figure 5.23 Averaged auto-spectra of CBFM, BPMCA, CVR for Treatment (blue) and
Control (red) group.
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Table 5.9 Integrated averaged auto-spectra within low and high frequency regions for
CBFM, BPMCA and CVR for the Treatment and Control group during stage 1 and stage4.
LF denotes frequency region 0.04-0.15Hz and HF denotes frequency region.
0.15Hz-0.32Hz. † significant differences between stage 1 (Treatment_1) and stage 4
(Treatment_4) of the treatment group; ‡ significant differences between stage 1
(Control_1) and stage 4 (Control_4) of the Control group.

Auto-spectra
LF
CBFM
HF
LF
BPMCA
HF
LF
CVR
HF

Treatment_1
0.27 ± 0.022
0.14 ±0.019
0.33 ± 0.057
0.084 ± 0.024
0.34 ± 0.056
0.11 ± 0.017

Treatment_4
0.31±0.040
0.27†±0.052
0.54†±0.040
0.13±0.015
0.49†±0.044
0.16±0.039

Control_1
0.29±0.018
0.14 ±0.016
0.33± 0.047
0.073 ±0.017
0.33± 0.034
0.10± 0.018

Control_4
0.37‡±0.052
0.17±0.041
0.51‡±0.048
0.18‡±0.044
0.496‡±0.061
0.13±0.020

There were no significant differences in the spectra of CBFM, BP MCA and CVR between
two groups during stage 4. For treatment group, integrated spectra of CBFM were higher
during stage 4 than that during stage 1 in the HF region. For Control group, integrated
spectra were higher during stage 4 than stage 1 in LF region. For both groups, in LF
region, the power in BP MCA and CVR during stage 4 was higher than during stage 1. For
Control group, the power in HF region of BP MCA is also higher during stage 4 than
during stage 1.
5.2.3

Coherence and transfer function gain between BPMCA and CBFM

Comparisons of coherence between two groups and within group between stage 4 and 1
are shown in Table 5.10. Group averaged coherencies between BPMCA and CBFM during
stage 4 are shown in Figure 5.24. Red curve shows control group and blue curve shows
treatment group. There were no significant differences between two groups. Within HF
region, the treatment group had a lower coherence during stage 4 than stage 1.
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Table 5.10 Integrated averaged coherence within low and high frequency regions
between BPMCA and CBFM/CVR for the Treatment and Control group during stage 1 and
stage 4. LF denotes frequency region 0.04-0.15Hz and HF denotes frequency region.
0.15Hz-0.32Hz. † significant differences between stage 1 (Treatment_1) and stage 4
(Treatment_4) of the treatment group; ‡ significant differences between stage 1
(Control_1) and stage 4 (Control_4) of the Control group.
Coherence
BPMCA-CBFM LF
HF
LF
BPMCA-CVR
HF

Treatment_1
8.90 ±1.45
14.25 ± 1.48
16.64 ±1.89
18.89 ± 1.85

Treatment_4
9.74±1.56
11.03†±1.14
20.69†±0.79
23.04†±1.82

Control_1
9.47 ± 1.37
13.34±1.49
18.69±1.15
19.81± 2.06

Control_4
11.47±1.31
12.10 ±1.11
20.01±0.90
24.69‡±0.95

Comparisons of transfer function gain between two groups and within group between
stage 4 and 1 are shown in Table 5.11. Both groups had a higher gain during stage 4
compared with baseline data within LF and HF region. As shown in Figure 5.25, transfer
function gain from BPMCA to CBFM during stage 4 was lower in the treatment group than
control group within LF region.
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Table 5.11 Integrated averaged transfer function gain within low and high frequency
regions between BPMCA and CBFM/CVR for the Treatment and Control group during
stage 1 and stage4. LF denotes frequency region 0.04-0.15Hz and HF denotes frequency
region. 0.15Hz-0.32Hz. † significant differences between stage 1 (Treatment_1) and
stage 4 (Treatment_4) of the treatment group; ‡ significant differences between stage 1
(Control_1) and stage 4 (Control_4) of the Control group; * significant differences
between Treatment and Control group during stage 4.

Transfer
gain

function Treatment_1

BPMCA-CBFM
BPMCA-CVR

LF
HF
LF
HF

10.07± 1.14
24.49 ±3.72
0.35 ±0.023
0.53 ±0.06

Treatment_4

Control_1

Control_4

5.37†±0.63
10.63†±1.80
0.41†±0.021
0.54±0.039

11.03 ±1.34
21.84 ±1.99
0.34 ±0.0079
0.45 ±0.028

7.59 ‡,* ±0.68
11.30‡±1.085
0.38‡±0.013
0.51±0.026

Treatment_4
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Figure 5.24 Averaged coherencies between BPMCA and CBFM during stage 4. Red curve
represents control group and blue represents treatment group.
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Figure 5.25 Averaged transfer function gain for Control group (Red) and Treatment group
(Blue) between BPMCA and CBFM during stage 4.
5.2.4 Coherencies and transfer function gain between BPMCA and CVR
As shown in Table 5.10 and Figure 5.26, there were no significant differences between
two groups in coherence between BPMCA and CVR during stage 4. For both groups, the
coherence during stage 4 was higher than baseline data in HF region. For treatment group,
the coherence is higher during stage 4 than baseline data in LF region.
As shown in Table 5.11 and Figure 5.27, there were no significant differences between
two groups in transfer function gain between BPMCA and CVR during stage 4. For both
groups the gain during stage 4 was higher than baseline data in LF region.
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Figure 5.26 Averaged coherencies for Control group (Red) and Treatment group (Blue)
between BPMCA and CVR during stage 4.
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Figure 5.27 Averaged transfer function gain for Control group (Red) and Treatment group
(Blue) between BPMCA and CVR during stage 4. Red curve denotes control group and
blue denotes treatment group.
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Chapter 6 Discussion
6.1

Ventilatory sensitivity to CO2

The main finding of this part of our study was that the dynamic sensitivity of the
ventilatory control system to perturbations in CO2 was enhanced during tilt. Combined
with the decrease in mean levels of ETCO2 and an increase in minute ventilation, our
results suggest that during tilt there may be a change in the ‘set point’ of PaCO2.
As discussed by Serrador et al (60), the reduction of ETCO2 during tilt may be due to
three mechanisms; active hyperventilation, which is an increase in alveolar ventilation
relative to CO2 production, increase in ventilation relative to cardiac output, and
redistribution of tissue CO2 stores. It is also possible that engagement of the vestibular
reflex causes an increase in ventilation, which may also contribute to the decrease in
ETCO2 (35). Irrespective of the mechanisms that result in the reduction of ETCO2, our
objective was to investigate how the CO2 control system adapts to, or accommodates, this
decrease.
Our results showed that gain and peak values of the impulse response increased
significantly during tilt relative to during supine, while the decay times showed a
tendency to decrease (non-significant). Each of these three measures indicated that the
ventilatory response to ETCO2 was enhanced during tilt. Serrador et al (60) observed that
CO2 production may slightly increase after 20 minutes of supine posture preceding tilt.
This observation combined with an increased dynamic sensitivity of the control system
would predict against the observed decrease in ETCO2. A possible mechanism that would
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account for these changes in sensitivity and ventilation is a decrease in the set point of
CO2. The set point of CO2 is the level of CO2 against which the afferent signal from CO2
receptors is compared (presumably at the sites of central regulation) in order to adjust
respiratory effort. Yoshizaki et al (71) had a similar explanation using a steady state
breathing technique to assess the sensitivity of the CO2 control system during tilt.
Yoshizaki et al observed that the slope of the ventilatory response to CO2 perturbations
remained unchanged during tilt while the curve was shifted leftward. They concluded that
the increase in minute and alveolar ventilation during tilt combined with unaltered
controller sensitivity indicated a change in CO2 regulatory set point. Different methods in
assessing system sensitivity may have contributed to the differences in the sensitivity
assessments by Yoshizaki et al (71) and our results. Consistent with our observations,
Jordan et al (27) also reported that the respiratory response to hypercapnia was enhanced
during tilt using steady state CO2 breathing. Initial results from a previous investigation
where we studied a small number of young adults and adolescent subjects using a similar
procedure also showed an increase in ventilatory sensitivity(58).
Collectively, our and others’ results suggest that the target value for CO2 regulation may
change during tilt. Our experiment cannot provide information regarding the mechanisms
via which the set point may change. However, we consider that additive excitatory neural
influences due to arousal state during tilt may have contributed to the increased
ventilation observed during tilt even though the CO2 levels were smaller. These types of
neural influences were modeled as an Alertness Factor by Longobardo et al (42) in their
recent modeling study. Another possible explanation for this change in “set point” could
be that ventilation control is nonlinear. The “set point” model is based on a linear
approximation. Changes in the “set point” actually reflect changes in the parameters of
the nonlinear system. “Set point” gives us a way to visualize those changes, but may not
directly point to the corresponding physiological changes.
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In contrast to open loop or controller responses, there were no significant differences in
comparison of closed loop responses between supine and tilt. Because of feedback loop,
closed loop responses are less sensitive to changes in controller sensitivity than the open
loop responses. Therefore, a likely explanation for not observing changes in closed loop
responses is that our experiment was not sensitive enough to detect these differences.
We observed blunting of the baroreflex sensitivity from 17.6 msec/mmHg to 5.5
msec/mmHg during tilt. Sequence analysis method was used to estimate the baroreflex
sensitivity, similar to the method used by Iellamo et al (26). It has been shown that
hyperventilation by itself, without any changes in ETCO2, can decrease baroreflex
sensitivity (66) from 13 msec/mmHg to 9 msec/mmHg. In a study by Laitinen et al.(38),
baroreflex sensitivity decreased from around 24 to 5 ms/mmHg. In their study subjects
were also tilted to 70-degree head up tilt position but only for 13 minutes. A slightly
larger decrease in baroreflex sensitivity was observed in our study. Baroreflex sensitivity,
in our study, was calculated during Tilt Control, i.e. during 10 to 30 minutes from the
onset of tilt. It is possible that the increased duration of tilt, combined with increased
ventilation due to washout of residual from inspired CO2, at least in the early part of tilt
control, might have contributed to the slightly larger decrease seen in our study.
In order to further verify our results obtained through the parametric method, we used a
non-parametric method to estimate the ventilatory responses to ETCO2 perturbations. As
shown in Figure 5.25, we found the transfer function gains were larger during tilt than
supine in almost all frequencies from DC to 0.12 Hz. These results provide further
support for our interpretation that the controller sensitivity (transfer function gain) was
augmented during tilt. The transfer functions showed that the differences between
responses during supine and tilt were more pronounced in the frequency region centered
around 0.09 Hz. Spectral results from blood pressure provide possible explanation for
increase in controller gain in this frequency region. Previous studies (53, 57) have shown
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that amplitudes of oscillations in mean and diastolic blood pressures at frequencies
around 0.1 Hz increase significantly during tilt. Results from our current study also
showed increase in amplitude of oscillations within this frequency range. Additionally,
within comparable frequency range, oscillations in cerebral blood flow have also been
shown to increase in amplitude during tilt (11). It is possible, therefore, that the increase
in amplitude of oscillations in pressure during tilt may translate into oscillations in
perfusion within the tissue where CO2 sensors are located. These changes in the perfusion
pressure may result in oscillations in sensed levels of CO2. Although speculative, the
above explanation is consistent with our observations: the responses to ETCO2 (resulting
ultimately from sensed arterial CO2) levels were augmented during tilt, while no change
in ventilatory response to inspired CO2 levels. If the above effect did play a role, then it is
possible that the central controller sensitivity may not have increased but the response or
output increased because of increased afferent signaling secondary to increased
oscillations in perfusion pressure.
This part of our study has several limitations. We estimated responses during PRBS
perturbations of lengths shorter than those used by others (37). Because of the possibility
of development of presyncope we used shorter periods for PRBS stimulation. However,
we ensured that the estimated responses from our study were comparable to those studies
that used longer data records. Additionally, as discussed by Lai and Bruce (37) use of
binary CO2 stimulation levels requires assumption of linearity of responses. This is an
assumption also shared by most of the previously studies involving estimates of
ventilatory sensitivities. In our study ETCO2 was used as the surrogate of PaCO2. Results
of previous studies (4, 6) suggest that the correlation between ETCO2 and PaCO2 may
change during tilt, and that postural changes in PaCO2 may be blunted with respect to
those of ETCO2. However, in these studies (4, 6), direct measurement of PaCO2
confirmed that PaCO2 also decreased during tilt. It is possible, therefore, a part of the
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increase in sensitivity indicated by our results may be attributed to a change in correlation
between PaCO2 and ETCO2.
In summary, our results suggest that the dynamic ventilatory response to perturbations in
ETCO2 is augmented during tilt relative to supine. The increase in ventilatory sensitivity
during head up tilt may produce more oscillations in ventilation. Our results suggest,
therefore, chemoreflex may play a role in the genesis of ventilatory oscillations prior to
the onset of pre-syncopal symptoms during head up tilt (39).
6.2

Gender differences in cerebral autoregulation

Consistent with previous studies (3, 45), women had higher CBFM during supine than
men. CBFM decreased during tilt in both groups. For similar reduction in ETCO2
(women: 46-42mmHg; men: 48-44mmHg), women had a larger drop in CBFM than men
(women: 76.74 to 67.52 cm/s; men: 66.99 to 62.52 cm/s). A higher CO2 reactivity in
women (32) may contribute to the larger drop in CBFM in women.
During Supine Control, women had a higher coherence between MBP and CBFM than
men within a frequency region 0.03-0.10 Hz and 0.22-0.31 Hz. In a similar frequency
region, the averaged transfer function gain between MBP and CBFM for women was also
higher than for men during Supine Control. Higher coherence observed in women
indicated that MBP for women was more related to CBFM than for men. Higher transfer
function gain suggested that for the same amount of changes in MBP, CBFM changed
more in women. Collectively, all these results suggested a less efficient CA in women
than in men during supine rest. These differences in cerebral auto-regulation are likely
influences from different hormone levels between women and men. Kastrup et. al. (31)
reported that the higher CBFM and higher CO2 vasodilator capacitances were diminished
by indomethacin. Since indomethacin is a prostacyclin inhibitor, Meyer and Rauch (47)
suggested that higher prostacyclin from cerebral arterial endothelium may attribute to
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higher CBFV in women, and may be related to estrogen effects. During Tilt PRBS and
Tilt Control the coherencies were significantly higher for men than for women, which
was not expected. Additionally, during tilt, the differences in CBFM disappeared.
In summary, gender-related differences in CA did exist and gender may need to be
considered as a factor in investigating CA.
6.3

Bispectral analysis

Our objective in using the bispectral analysis was to investigate alterations in non-linear
phase coupling among cardio-respiratory signals in response to baro and chemo reflex
stimuli. We explored these changes in non-linear cardio-respiratory interactions in
presyncopal group and non-presyncopal group. We estimated auto-bispectra of RR
intervals, SBP, and cross-bispectra between RR-SBP, RR-Vt, CBFM-ETCO2 and
CBFM-SBP. Our results showed that both RR interval and SBP phase coupling was
lower in the presyncopal group than in non-presyncopals prior to onset of presyncopal
symptoms.
Previous studies (8, 14, 22) have shown nonlinear components in the regulation of heart
rate and blood pressure. Braun et. al (8) demonstrated that nonlinear components do exist
in heart rate variability of healthy subject . However, physiological origins of these
nonlinear components are not clearly identified. Kanters et. al. (28) concluded that
nonlinear dynamics in heart rate does not come from respiration since nonlinear
dynamics in heart rate existed even with fixed breathing rates. However, in Kanters’
study, only breathing rate was controlled not tidal volume or ventilation. A previous
study (55) clearly showed that variations in tidal volume, produced as an amplitude
modulation, without changes in breathing rate, can importantly change the low frequency
component of RR interval. Therefore, we cannot conclude that nonlinear components do
not relate to respiration activity. Gonzalez et. al. (22) found that nonlinear components in
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RR interval variability in rats appeared to be influenced more by parasympathetic activity
while that in SBP variability seemed to be related to respiration via a non-neural pathway.
Dabire et. al. (14) used pharmacological blockers and recurrence plots to determine that
nonlinear indexes of RR intervals in normotensive rats increased when parasympathetic
activity was blocked. The index of nonlinear coupling that we used (bispectral power) is
different from previous indexes, therefore the physiologic correlates of our bispectral
phase coupling index are not entirely clear from previous studies, but may be determined
from the orthostatic response in non-presyncopal group.
We observed in the non-presyncopal subjects that phase coupling in RR interval
decreased and phase coupling in SBP increased during tilt. It is generally accepted that
the normal orthostatic response includes a decrease in vagal tone and a slight
enhancement in sympathetic activity. Our results suggest that a decrease in RR interval
phase coupling is related to decrease in vagal activity while increase in SBP phase
coupling is related to increased sympathetic activity. We observed that the RR interval
phase coupling decreased in both groups during Tilt Control compared to that with during
Supine Control. In the presyncopal group, the RR interval phase coupling was lower
compared with non-presyncopal group during Tilt Control in the frequency region II
(0.15-0.3, 0.04-0.15 Hz) and III (0.15-0.3, 0.15-0.3Hz). These observations suggest that
vagal input to cardiovascular regulation was diminished in both groups, however, the
decrease in presyncopal group prior to onset of presyncopal symptoms was more
pronounced than that in the non-presyncopal group. In both groups the SBP phase
coupling increased during Tilt Control compared with during Supine Control. The
presyncopal group had a lower SBP phase coupling in region III (i.e. high frequency
region, 0.15-0.3, 0.15-0.3 Hz) during Tilt Control than non-presyncopal group. These
observations suggest that sympathetic activity increased for both groups however subjects
who developed pre-syncope increased it less than the non-presyncopal group. In a
previous study by Convertino et al.(12), they also reported sympathetic withdrawal and
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vagal tone enhancement prior to presyncope. Although our results also suggest
diminished sympathetic activity in presyncopal group prior to the onset of presyncope,
our results do not suggest an increase in vagal activity.
We observed that, in non-presyncopal subjects, stimulating the chemoreflex during
supine (Supine PRBS) resulted in increased phase coupling between RR-intervals and
SBP. During Tilt Control, the coupling decreased in both groups. Comparison between
groups showed that the presyncopal group had a lower phase coupling compared with
non-presyncopal group. Previous results suggest that RR-SBP coupling may involve
respiration via the parasympathetic system (22). It is possible that stimulation of the
chemoreflex affected respiratory pattern and, through either mechanical coupling or via
the parasympathetic efferents, decreased phase coupling between RR interval and SBP.
Although the physiological interpretation of coupling between RR and SBP is not entirely
clear, a possible link may be mechanical via amplitude modulation type phenomenon. As
discussed by Witte et al (69), the phase coupling estimated by bispectrum, also referred to
as quadratic phase coupling (QPC), can result from amplitude modulation. An example
discussed by Witte et al illustrates this point clearly. We provide this example here
briefly: considering two signals A and B such that A=sin(2πf1t+θ1); B= sin(2πf2t+θ2); if
A modulates B, and the resultant signal is added to A to obtain a new signal H(t), H(t)
then includes power at frequencies f1, f2, f2-f1 and f2+f1. If the phase relations (θ1+ θ2, θ2θ1) remain relatively unchanged, then the bispectrum of H(t) will have power at
frequencies f1,f2. According to the above operation, power in a bispectrum indicates a
fixed phase relation between θ1, θ2 and also a non-linear coupling between frequencies.
Reduced coupling between RR and SBP and RR and Tidal volume observed in the
presyncopal group during Tilt Control, therefore, suggests that some degree of
disassociation of cardio-respiratory interaction. This interpretation is consistent with the
results of a study by Lipstiz et al. (39) who used complex demodulation to show that
cardio-respiratory interaction decoupled before the onset of syncope.
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Arterial partial pressure of CO2 (of which ETCO2 is a surrogate) and SBP are two
important factors affecting CBFV. In both groups, we observed that both tilt and
stimulating the chemoreflex enhanced phase coupling between CBFM and ETCO2. These
results suggest a larger role of CO2 tension mediated changes in CBFV via amplitude
modulation type phenomenon during PRBS (where ETCO2 and, therefore, arterial partial
pressure of CO2 changed by design) and during tilt compared with Supine Control.
Between-group comparison showed that the presyncopal group had less coupling during
Tilt PRBS compared with non-presyncopal group. These results suggest that this
amplitude modulation type coupling was less effective in presyncopals. We have
previously reported (33), that the CO2 reactivity to CBFV was less in the presyncopal
group. Whether the decrease in reactivity was related to the decreased modulation of
CBFV is not entirely clear.
Cross-bispectrum between CBFV and SBP may reflect nonlinear dynamics in cerebral
autoregulation. We observed an increase in the phase coupling during tilt (Table I).
Comparison between groups showed that the phase coupling between CBFM and SBP
during Tilt Control was higher in the presyncopal group than the non-presyncopal group,
which may reflect diminished cerebral autoregulation. Our previous studies using linear
methods (33), reported that presyncopal subjects had higher coherence and gain between
SBP and CBFM which also suggested diminished CA. This result from our previous
studies is consistent with our current interpretation.
An advantage of using bispectral analysis is that it allows us to explore nonlinear
components within cardio-respiratory variables. Our results clearly show that such
components do exist within these regulatory systems and that they will be affected by
orthostatic stress, further, they are different based on the response to orthostatic stress (i.e.
occurrence of pre-syncope). Whether such indexes are better predictors than others of
pre-syncope remains unclear, however, our results provide support for such investigation.
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Further investigation using these indexes is warranted to explore physiological origins of
non-linear phase coupling within cardio-respiratory signals.
6.4

Hypocapnia effects on cerebral autoregulation

Our main findings in this part of the study were that in the transfer function gain between
BPMCA and CBFM in the treatment group was lower than control group in the LF region.
The transfer function gain between BPMCA and CBFM for the treatment group was lower
than the control group in LF in stage 4 which suggest that the oscillations in BPMCA are
less transferred into the changes in CBFM during hypocapnia than normocapnia. Greater
transfer gain between BPMCA and CBFM suggested impaired autoregulation (72). Our
results, therefore, mean hypocapnia improved the autoregulation compared with
normocapnia.
We observed for both groups BPMCA power increased during stage 4 relative to stage 1 in
the LF region. The increase might come from tilt effects. Similar to the results from
experiment one, the blood pressure variability increased in the LF region during tilt
compared with during supine.
We observed peaks in the auto-spectrum of BPMCA CVR and CBFM corresponding to the
respiratory frequencies and their multiple harmonics as shown in Figure 5.23. In the
coherence between BPMCA and CBFM, we also observed peaks in similar frequency
regions. As seen from Figure 5.24, in the treatment group the peaks at respiratory
frequency region (around 0.22Hz) were very obvious. While in the control group, this is
not so obvious. These results suggest that during controlled breathing both blood pressure
and CBFV were modulated at the respiratory frequency, similar to the result from a
recent study by Eames et. al. (15).
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In a recent study by Edwards et. al (17), they used similar dynamic method to investigate
the CA. In their study, auditory signal was used to fix the breathing rate at 15 breaths/min
along with an ETCO2 forcing system to maintain the ETCO2 level. Their results showed
the gain for BPMCA and CVR was enhanced with hypocapnia and diminished with
hypercapnia compared with normocapnia indicating improved cerebral autoregulation
under hypocapnia and impaired autoregulation in hypercapnia. Our analysis did not show
significant differences for relation between BPMCA and CVR between the two groups.
The conclusion we obtained from the relation between BPMCA and CBFM is consistent
with theirs. In another study by Edwards et. al. (16), they used an ARMA model to
investigate the interactions of CO2 level and BPMCA oscillation on cerebrovascular
response simultaneously. In their study, subjects breathed in two breaths of CO2 balanced
with air to elicit the responses. They suggested when CO2 level increased the
cerebrovascular responsiveness to changes in CO2 or BPMCA was reduced. These results
also suggested that during normocapnia compared with hypocapnia the CA was less
efficient. A recent study (46)also reported that, compared with normocapnia, hypocapnia
helped more subjects restore CA during isoflurane-induced impairment of CA. However,
as mentioned before, hypocapnia is expected to increase CVR, thus the CBF is expected
to decrease accordingly, which may support an increase in the probability of developing
syncope. Therefore, whether improved CA during hypocapnia indicates increased or
decreased probability of developing syncope remains unclear.
In summary, our results showed decreased variabilities in CBFM in VLF region, lower
gain between BPMCA and CBFM in the HF region. All the above results showed improved
CA during hypocapnia compared with during normocapnia when changes in ventilation
were minimized. Whether impaired CA is related to an increased probability of
developing syncope needs to be further investigated.
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